Details of Xenobiotics-DME Interaction (XEOTIC)

General Information of Drug-Metabolizing Enzyme (DME ID: DME1110)
DME Name Arylamine N-acetyltransferase (NAT), Pseudomonas aeruginosa DME Info
UniProt ID
A0A5E5R1G5_PSEAI
EC Number    EC: 2.3.1.5     (Click to Show/Hide the Complete EC Tree)
Transferase
Acyltransferase
Acyltransferase
EC: 2.3.1.5
Lineage    Species: Pseudomonas aeruginosa     (Click to Show/Hide the Complete Species Lineage)
Kingdom: Bacteria
Phylum: Proteobacteria
Class: Gammaproteobacteria
Order: Pseudomonadales
Family: Pseudomonadaceae
Genus: Pseudomonas
Species: Pseudomonas aeruginosa
Interactome
Interactions between Xenobiotics and DME (XEOTIC)
      Amino Acid(s), Peptide(s) or Protein(s)
                  Amino Acid Click to Show/Hide the Full List of Xenobiotics:        1 Xenobiotics
                              Picolinic acid Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04603   XEOTIC Info Gene Form Protein
                                 Classification Amino Acid
                                 DME Modulation Picolinic acid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [1]
                  Peptide Click to Show/Hide the Full List of Xenobiotics:    566 Xenobiotics
                              A. clavatus peptide AcAMP Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02122   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation A. clavatus peptide AcAMP inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 50 ug/ml) [2]
                              Acylase Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02134   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Acylase inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [3]
                              Agelaia-mastoparan Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02147   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Agelaia-mastoparan inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 257 ug/ml) [4], [5]
                              AI-hemocidins 1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02149   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation AI-hemocidins 1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 47.35 microM) [6]
                              AI-hemocidins 3 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02150   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation AI-hemocidins 3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 95.37 microM) [6]
                              Amphipathic peptide StCT1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02200   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Amphipathic peptide StCT1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 100 ug/ml) [7]
                              Amphipathic peptide StCT2 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02201   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Amphipathic peptide StCT2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 100 ug/ml) [8]
                              Amphiphatic peptide VmCT1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02202   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Amphiphatic peptide VmCT1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 10 microM) [9]
                              Amphiphatic peptide VmCT2 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02203   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Amphiphatic peptide VmCT2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 10 microM) [9]
                              Andropin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02226   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Andropin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 300 microM) [10]
                              Anopheles cecropin-A amidated isoform Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02230   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Anopheles cecropin-A amidated isoform inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1-2.5 microM) [11], [12]
                              Anti-lipopolysaccharide factor PtALF5 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04758   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Anti-lipopolysaccharide factor PtALF5 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 15.54-31.08 microM) [13], [14]
                              Anti-lipopolysaccharide factor PtALF6 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04759   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Anti-lipopolysaccharide factor PtALF6 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 9.32-18.64 microM) [13], [15]
                              Anti-lipopolysaccharide factor PtALF7 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04760   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Anti-lipopolysaccharide factor PtALF7 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1.02-2.04 microM) [13], [16]
                              Antibacterial peptide PMAP-23 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02242   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Antibacterial peptide PMAP-23 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 16 microM) [17]
                              Antibacterial peptide PMAP-36 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02243   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Antibacterial peptide PMAP-36 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 3 microM) [18]
                              Antibacterial peptide PMAP-37 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02244   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Antibacterial peptide PMAP-37 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2 microM) [19]
                              Antibacterial protein LL-37 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02247   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Antibacterial protein LL-37 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [20]
                              Antibacterial protein PR-39 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02248   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Antibacterial protein PR-39 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 200 microM) [21], [22]
                              Anticancerous peptide Cr-ACP1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02249   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Anticancerous peptide Cr-ACP1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 30 microM) [23]
                              Antifungal protein ginkbilobin-1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02253   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Antifungal protein ginkbilobin-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [24]
                              Antimicrobial peptide Cn-AMP1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02261   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Antimicrobial peptide Cn-AMP1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 79 ug/ml) [25]
                              Antimicrobial peptide Cn-AMP2 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02268   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Antimicrobial peptide Cn-AMP2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 169 ug/ml) [25]
                              Antimicrobial peptide Cn-AMP3 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02271   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Antimicrobial peptide Cn-AMP3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 259 ug/ml) [25]
                              Antimicrobial peptide eNAP-1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02280   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Antimicrobial peptide eNAP-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [26]
                              Antimicrobial peptide eNAP-2 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02281   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Antimicrobial peptide eNAP-2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [27], [28]
                              Antimicrobial peptide HP(2-20) Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02283   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Antimicrobial peptide HP(2-20) inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 6.25 ug/ml) [29]
                              Antimicrobial peptide PGQ Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02294   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Antimicrobial peptide PGQ inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 250-500 ug/ml) [30]
                              Antimicrobial peptide XT-6 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02275   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Antimicrobial peptide XT-6 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 60 microM) [31]
                              Antimicrobial protein AMP1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02297   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Antimicrobial protein AMP1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC < 25 ug/ml) [32]
                              Arachnid gomesin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03497   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Arachnid gomesin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1.6-3.15 microM) [33]
                              Arthropod UyCT1 peptide Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05206   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Arthropod UyCT1 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 10 microM) [34]
                              Arthropod UyCT2 peptide Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05207   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Arthropod UyCT2 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 40 microM) [34]
                              Arthropod UyCT3 peptide Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05208   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Arthropod UyCT3 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 6 microM) [34]
                              Arthropod UyCT5 peptide Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05209   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Arthropod UyCT5 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2 microM) [34]
                              Ascaphin-5 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02325   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Ascaphin-5 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 13 microM) [35]
                              Bac2A scrambled variant Bac014 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02352   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Bac2A scrambled variant Bac014 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 23 ug/ml) [36]
                              Bac2A scrambled variant Bac020 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02353   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Bac2A scrambled variant Bac020 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 11 ug/ml) [36]
                              Bac2A scrambled variant Bac034 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02354   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Bac2A scrambled variant Bac034 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 25 ug/ml) [36]
                              Bac2A scrambled variant F3 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03379   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Bac2A scrambled variant F3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 6 ug/ml) [36]
                              Bac2A scrambled variant K12 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03679   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Bac2A scrambled variant K12 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 6 ug/ml) [36]
                              Bac2A scrambled variant opt1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04400   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Bac2A scrambled variant opt1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 6 ug/ml) [36]
                              Bac2A scrambled variant opt2 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04401   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Bac2A scrambled variant opt2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 3 ug/ml) [36]
                              Bac2A scrambled variant opt3 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04402   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Bac2A scrambled variant opt3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 6 ug/ml) [36]
                              Bac2A scrambled variant opt4 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04403   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Bac2A scrambled variant opt4 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 6 ug/ml) [36]
                              Bac2A scrambled variant opt5 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04404   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Bac2A scrambled variant opt5 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 3 ug/ml) [36]
                              Bac2A scrambled variant R10 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04782   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Bac2A scrambled variant R10 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 12 ug/ml) [36]
                              Bac2A scrambled variant W3 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05268   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Bac2A scrambled variant W3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 6 ug/ml) [36]
                              Bac2A scrambled variant W4 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05269   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Bac2A scrambled variant W4 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 50 ug/ml) [36]
                              Bac2A variant Bac8a Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02357   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Bac2A variant Bac8a inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 16 ug/ml) [37]
                              Bac2A variant Bac8b Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02358   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Bac2A variant Bac8b inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 16 ug/ml) [37]
                              Bac2A variant Bac8c Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02360   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Bac2A variant Bac8c inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 8 ug/ml) [37]
                              Bac2A variant Bac8d Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02361   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Bac2A variant Bac8d inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 250 ug/ml) [37]
                              Bac2A variant G1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03428   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Bac2A variant G1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 125 ug/ml) [37]
                              Bac2A variant G12 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03430   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Bac2A variant G12 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 63 ug/ml) [37]
                              Bac2A variant G2 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03434   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Bac2A variant G2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 31 ug/ml) [37]
                              Bac2A variant K7 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03684   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Bac2A variant K7 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 31 ug/ml) [37]
                              Bac2A variant R11 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04783   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Bac2A variant R11 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 16 ug/ml) [37]
                              Bac2A variant R2 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04784   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Bac2A variant R2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 8 ug/ml) [37]
                              Bac2A variant R3 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04785   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Bac2A variant R3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 8 ug/ml) [37]
                              Bac2A variant R5 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04786   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Bac2A variant R5 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 63 ug/ml) [37]
                              Bac2A variant Sub2 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05000   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Bac2A variant Sub2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 8 ug/ml) [37]
                              Bac2A variant Sub3 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05001   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Bac2A variant Sub3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2 ug/ml) [37]
                              Bac2A variant Sub5 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05002   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Bac2A variant Sub5 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2 ug/ml) [37]
                              Bac2A variant Sub6 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05003   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Bac2A variant Sub6 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 31 ug/ml) [37]
                              Bac2A variant W10 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05264   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Bac2A variant W10 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 16 ug/ml) [37]
                              Bac2A variant W3 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05267   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Bac2A variant W3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 8 ug/ml) [37]
                              Bactenecin 7 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02371   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Bactenecin 7 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 50 ug/ml) [38]
                              Bactenecin bac2I-NH2 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02356   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Bactenecin bac2I-NH2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 16 ug/ml) [39]
                              Bactenecin bacP2R-NH2 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02366   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Bactenecin bacP2R-NH2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 16 ug/ml) [39]
                              Bactenecin bacP3R-V Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02368   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Bactenecin bacP3R-V inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 8 ug/ml) [39]
                              Bactenecin cyclic derivative BacP1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02365   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Bactenecin cyclic derivative BacP1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 64 ug/ml) [39]
                              Bactenecin cyclic derivative BacP3R Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02367   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Bactenecin cyclic derivative BacP3R inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 8 ug/ml) [39]
                              Bactenecin cyclic derivative BacR Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02369   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Bactenecin cyclic derivative BacR inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 4 ug/ml) [39]
                              Bactenecin cyclic derivative BacW Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02388   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Bactenecin cyclic derivative BacW inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 4 ug/ml) [39]
                              Bactenecin cyclic derivative BacW2R Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02389   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Bactenecin cyclic derivative BacW2R inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2 ug/ml) [39]
                              Bactenecin-5 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02735   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Bactenecin-5 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1 ug/ml) [40]
                              Bacteriocin delta-lysin I Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03137   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Bacteriocin delta-lysin I inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [41]
                              Bacteriocin L-1077 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02378   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Bacteriocin L-1077 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 0.38 ug/ml) [42]
                              Bactridin-1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02386   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Bactridin-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 77 microM) [43], [44]
                              Bactridin-2 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02387   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Bactridin-2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 54 microM) [43], [44]
                              Beta-defensin BD-1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02437   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Beta-defensin BD-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [45]
                              Beta-defensin BD-3 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02438   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Beta-defensin BD-3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [46]
                              Beta-defensin BD-38 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02440   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Beta-defensin BD-38 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [47]
                              Beta-defensin BD-8 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02443   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Beta-defensin BD-8 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [48]
                              Biologically active peptide BmKn2 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04541   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Biologically active peptide BmKn2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 21.3 ug/ml) [49]
                              bLF peptide Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02462   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation bLF peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [50]
                              BMAP-27 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02464   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation BMAP-27 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [51]
                              BMAP-28 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02465   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation BMAP-28 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [51]
                              BmKn2 derivative Kn2-7 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03709   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation BmKn2 derivative Kn2-7 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 100 ug/ml) [52]
                              Bombinin-like peptide BLP-3 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02475   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Bombinin-like peptide BLP-3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 9.2 microM) [53]
                              Bovine cathelicidin BMAP-34 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02466   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Bovine cathelicidin BMAP-34 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC <= 18 microM) [54], [55]
                              Bovine dodecapeptide linear variant Bac2A Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02355   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Bovine dodecapeptide linear variant Bac2A inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 50 ug/ml) [37], [36]
                              Bradykinin-potentiating BmK3 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02491   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Bradykinin-potentiating BmK3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 4.7 microM) [56], [57]
                              Brevinin-1AUa Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02496   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Brevinin-1AUa inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 25 microM) [58]
                              Brevinin-1AUb Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02497   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Brevinin-1AUb inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 25 microM) [58]
                              Brevinin-1CG4 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02511   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Brevinin-1CG4 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 75 microM) [59]
                              Brevinin-1CG5 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02512   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Brevinin-1CG5 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 75 microM) [59]
                              Brevinin-1E Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02521   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Brevinin-1E inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 30.6 microM) [60], [61]
                              Brevinin-1E15 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02492   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Brevinin-1E15 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 50 ug/ml) [62]
                              Brevinin-1E18 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02493   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Brevinin-1E18 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 12.5 ug/ml) [62]
                              Brevinin-1E21 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02494   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Brevinin-1E21 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 12.5 ug/ml) [62]
                              Brevinin-1RTa Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02554   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Brevinin-1RTa inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [63]
                              Brevinin-1TSa Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02566   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Brevinin-1TSa inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 50 microM) [64]
                              Brevinin-1ZHa Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02575   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Brevinin-1ZHa inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 32 microM) [65]
                              Brevinin-1ZHb Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02576   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Brevinin-1ZHb inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 44 microM) [65]
                              Brevinin-2-RN1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02630   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Brevinin-2-RN1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 12.5 ug/ml) [66]
                              Brevinin-2-RN2 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02631   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Brevinin-2-RN2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 12.5 ug/ml) [66]
                              Brevinin-2E Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02584   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Brevinin-2E inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 30 microM) [60]
                              Brevinin-2LTa Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02598   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Brevinin-2LTa inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 65 microM) [67]
                              Brevinin-2LTb Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02599   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Brevinin-2LTb inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 30 microM) [67]
                              Brevinin-2TSa Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02637   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Brevinin-2TSa inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 6 microM) [64]
                              Brevinin-2ZHa Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02639   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Brevinin-2ZHa inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 5 microM) [65]
                              Calcitermin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02703   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Calcitermin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [68]
                              CAMA peptide Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02705   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation CAMA peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [69]
                              CAP18 fragment CAP7 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02709   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation CAP18 fragment CAP7 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 0.05 microM) [70]
                              Cathelicidin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02731   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Cathelicidin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 0.63 microM) [71]
                              Cathelicidin cjaRL-37 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02864   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Cathelicidin cjaRL-37 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2 microM) [20]
                              Cathelicidin CP-11 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02931   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Cathelicidin CP-11 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 64 ug/ml) [72], [73]
                              Cathelicidin HmdSL-37 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03579   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Cathelicidin HmdSL-37 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [20]
                              Cathelicidin PobRL-37 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04680   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Cathelicidin PobRL-37 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 0.5-1 microM) [20]
                              Cathelicidin SMAP-34 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04957   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Cathelicidin SMAP-34 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 0.77 microM) [74]
                              Cathelicidin-1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02732   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Cathelicidin-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1.25 microM) [75]
                              Cathelicidin-5 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02739   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Cathelicidin-5 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1 microM) [76], [77]
                              Cathelicidin-6 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02740   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Cathelicidin-6 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1 ug/ml) [76], [78]
                              Cathelicidin-BF Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02743   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Cathelicidin-BF inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1.2 ug/ml) [79], [80]
                              cathelicidin-BF15 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02744   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation cathelicidin-BF15 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 4.7 ug/ml) [79]
                              Cathelicidin-NA Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02745   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Cathelicidin-NA inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [80]
                              Cathelicidin-OH Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02746   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Cathelicidin-OH inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [80]
                              Cathelin-related antimicrobial peptide rCRAMP Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04839   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Cathelin-related antimicrobial peptide rCRAMP inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [74]
                              Cathelin-related peptide SC5 SMAP-29 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04955   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Cathelin-related peptide SC5 SMAP-29 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 0.08 microM) [81], [82]
                              ccTP derivative Arg13 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO01812   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation ccTP derivative Arg13 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 6.2 microM) [83]
                              ccTP derivative Arg4,8 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO01815   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation ccTP derivative Arg4,8 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 8.0 microM) [83]
                              ccTP derivative Arg4,8,13 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO01814   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation ccTP derivative Arg4,8,13 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 3.9 microM) [83]
                              ccTP derivative Arg4,8,13 Lys18 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO01813   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation ccTP derivative Arg4,8,13 Lys18 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2.0 microM) [83]
                              Cecropin-A(1-7)-melittin(1-8) hybrid Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02756   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Cecropin-A(1-7)-melittin(1-8) hybrid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 15 microM) [84]
                              Cecropin-A(1-7)-melittin(2-9) hybrid Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02757   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Cecropin-A(1-7)-melittin(2-9) hybrid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 4 microM) [84], [85]
                              Cecropin-A(1-7)-melittin(3-10) hybrid Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02758   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Cecropin-A(1-7)-melittin(3-10) hybrid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 15 microM) [84]
                              Cecropin-A(1-7)-melittin(4-11) hybrid Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02759   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Cecropin-A(1-7)-melittin(4-11) hybrid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 4 microM) [84], [86]
                              Cecropin-A(1-7)-melittin(5-12) hybrid Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02760   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Cecropin-A(1-7)-melittin(5-12) hybrid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2 microM) [84]
                              Cecropin-A(1-7)-melittin(6-13) hybrid Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02761   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Cecropin-A(1-7)-melittin(6-13) hybrid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 8 microM) [84]
                              Cecropin-A(1-8)-Magainin-2(1-12) hybrid P18 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04430   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Cecropin-A(1-8)-Magainin-2(1-12) hybrid P18 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1.56 microM) [87], [88]
                              Cecropin-A(1-8)-melittin(1-10) hybrid Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02762   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Cecropin-A(1-8)-melittin(1-10) hybrid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 3 microM) [84]
                              Cecropin-A(1-8)-melittin(1-12) hybrid Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02763   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Cecropin-A(1-8)-melittin(1-12) hybrid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 0.9 microM) [84]
                              Cecropin-A(1-8)-melittin(1-13) hybrid Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02764   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Cecropin-A(1-8)-melittin(1-13) hybrid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1 microM) [84]
                              Cecropin-A(1-8)-melittin(1-18) hybrid Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02765   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Cecropin-A(1-8)-melittin(1-18) hybrid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 0.7 microM) [84]
                              Cecropin-B Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02766   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Cecropin-B inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [89]
                              Cecropin-B(1-7)-melittin(4-11) hybrid Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02767   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Cecropin-B(1-7)-melittin(4-11) hybrid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [86]
                              Cecropin-D Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02771   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Cecropin-D inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 81 microM) [90]
                              Cecropin-P1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02774   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Cecropin-P1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 5.9 microM) [91], [92]
                              CEMA protein MBI-28 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02799   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation CEMA protein MBI-28 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2 ug/ml) [93]
                              CEME protein MBI-27 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02800   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation CEME protein MBI-27 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2 ug/ml) [93]
                              Ceratotoxin-C Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02802   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Ceratotoxin-C inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 50 microM) [94]
                              Chensinin-1ZHa Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02824   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Chensinin-1ZHa inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 9 microM) [65]
                              Cliotide cT1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02875   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Cliotide cT1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2.7 microM) [95]
                              Cliotide cT2 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02876   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Cliotide cT2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 100 microM) [95]
                              Cliotide cT3 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02877   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Cliotide cT3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 100 microM) [95]
                              Cliotide cT4 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02878   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Cliotide cT4 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1.9 microM) [95]
                              CM1 peptide Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02885   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation CM1 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 16 ug/ml) [93]
                              CM2 peptide Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02886   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation CM2 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1 ug/ml) [93]
                              CM3 peptide Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02887   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation CM3 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2 ug/ml) [93]
                              CM4 peptide Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02888   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation CM4 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 3 ug/ml) [93]
                              CM5 peptide Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02889   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation CM5 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 19 ug/ml) [93]
                              CM6 peptide Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02890   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation CM6 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1 ug/ml) [93]
                              CM7 peptide Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02891   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation CM7 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 16 ug/ml) [93]
                              CP alpha 1 peptide Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02947   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation CP alpha 1 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 16 ug/ml) [93]
                              CP alpha 2 peptide Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02948   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation CP alpha 2 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2 ug/ml) [93]
                              CP alpha 3 peptide Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02949   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation CP alpha 3 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 16 ug/ml) [93]
                              CP-P derivative A9 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02110   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation CP-P derivative A9 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 25 ug/ml) [96]
                              CP-P derivative A10 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02103   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation CP-P derivative A10 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 12.5 ug/ml) [96]
                              CP-P derivative A13 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02107   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation CP-P derivative A13 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 6.25 ug/ml) [96]
                              CP-P derivative D11 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03050   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation CP-P derivative D11 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 25 ug/ml) [96]
                              CP-P derivative D18 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03054   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation CP-P derivative D18 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 25 ug/ml) [96]
                              CP-P derivative F2 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03377   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation CP-P derivative F2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 12.5 ug/ml) [96]
                              CP-P derivative K11 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03678   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation CP-P derivative K11 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 4 ug/ml) [96]
                              CP-P derivative K17 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03680   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation CP-P derivative K17 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 12.5 ug/ml) [96]
                              CP-P derivative K6 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03683   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation CP-P derivative K6 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 12.5 ug/ml) [96]
                              CP-P derivative L10 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03725   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation CP-P derivative L10 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 12.5 ug/ml) [96]
                              CP-P derivative N18 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04213   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation CP-P derivative N18 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 6.25 ug/ml) [96]
                              CP-P derivative N20 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04215   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation CP-P derivative N20 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 6.25 ug/ml) [96]
                              CP-P derivative N3 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04217   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation CP-P derivative N3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 12.5 ug/ml) [96]
                              CP-P derivative N7 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04223   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation CP-P derivative N7 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 12.5 ug/ml) [96]
                              CP-P derivative S16 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04888   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation CP-P derivative S16 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 3.125 ug/ml) [96]
                              CP-P derivative S9 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04890   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation CP-P derivative S9 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 50 ug/ml) [96]
                              CP-P peptide Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02943   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation CP-P peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 12.5 ug/ml) [97]
                              CP201 peptide Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02933   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation CP201 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 16 ug/ml) [93]
                              CP202 peptide Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02934   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation CP202 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 16 ug/ml) [93]
                              CP203 peptide Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02935   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation CP203 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 3 ug/ml) [93]
                              CP206 peptide Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02936   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation CP206 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 16 ug/ml) [93]
                              CP207 peptide Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02937   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation CP207 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 3 ug/ml) [93]
                              CP208 peptide Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02938   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation CP208 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 64 ug/ml) [93]
                              CP209 peptide Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02939   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation CP209 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 64 ug/ml) [93]
                              CP26 peptide Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02940   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation CP26 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1 ug/ml) [93]
                              CP29 peptide Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02941   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation CP29 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2 ug/ml) [93]
                              Ctx(Ile21)-Ha-I9K peptide Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02969   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Ctx(Ile21)-Ha-I9K peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 32 microM) [98]
                              CTX-1 peptide NCP-3a Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04241   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation CTX-1 peptide NCP-3a inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [99]
                              CTX-1 peptide NCP-3b Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04242   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation CTX-1 peptide NCP-3b inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [99]
                              Ctx-Ha peptide derivative Ctx(Ile21)-Ha Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02971   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Ctx-Ha peptide derivative Ctx(Ile21)-Ha inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 128 microM) [98]
                              Cupiennin-1D Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03021   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Cupiennin-1D inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 0.31-0.63 microM) [100], [101]
                              Cyclic cationic V1 peptide Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03029   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Cyclic cationic V1 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 0.619 microM) [102]
                              Cyclic cationic V2 peptide Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03030   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Cyclic cationic V2 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 0.643 microM) [102]
                              Cyclic cationic V3 peptide Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03031   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Cyclic cationic V3 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 0.005 microM) [102]
                              Cyclic cationic V4 peptide Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03032   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Cyclic cationic V4 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 0.005 microM) [102]
                              Cyclic cationic V5 peptide Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03033   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Cyclic cationic V5 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 0.005 microM) [102]
                              Cyclic cationic V6 peptide Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03034   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Cyclic cationic V6 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 0.004 microM) [102]
                              Cyclic cationic V7 peptide Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03035   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Cyclic cationic V7 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 0.004 microM) [102]
                              Cyclic protegrin-1-mimetic L27-11 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03036   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Cyclic protegrin-1-mimetic L27-11 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [103]
                              Cyclopsychotride-A Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03039   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Cyclopsychotride-A inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 13.5 microM) [104], [105]
                              Cytotoxic linear peptide IsCT Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03043   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Cytotoxic linear peptide IsCT inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2 microM) [106], [107]
                              D-amino acid substitution of K9L8W Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03060   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation D-amino acid substitution of K9L8W inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2 microM) [108]
                              D-amino-acid pexiganan MSI-214 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03073   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation D-amino-acid pexiganan MSI-214 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 16-32 ug/ml) [109]
                              D-LAK60 peptide Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03210   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation D-LAK60 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 22.62 microM) [110]
                              D-LAK80 peptide Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03211   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation D-LAK80 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 22.62 microM) [110]
                              D0-NH2 peptide Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03049   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation D0-NH2 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 100 microM) [96]
                              D1-NH2 peptide Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03055   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation D1-NH2 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 100 microM) [96]
                              D2-NH2 peptide Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03059   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation D2-NH2 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 12 microM) [96]
                              D3-NH2 peptide Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03062   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation D3-NH2 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 6 microM) [96]
                              D4-NH2 peptide Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03064   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation D4-NH2 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 6 microM) [96]
                              D5-NH2 peptide Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03066   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation D5-NH2 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 3 microM) [96]
                              D6-NH2 peptide Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03068   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation D6-NH2 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 3 microM) [96]
                              Defensin-like AMP pelovaterin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04503   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Defensin-like AMP pelovaterin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [111], [112]
                              Defensin-like longicornsin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03958   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Defensin-like longicornsin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [113]
                              Defensin-like protein fabatin-2 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03123   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Defensin-like protein fabatin-2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [114]
                              Defensin-NV Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03126   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Defensin-NV inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 9.3 microM) [115]
                              Dermadistinctin DD K Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03145   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Dermadistinctin DD K inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2.4 microM) [116]
                              Dermadistinctin DD L Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03146   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Dermadistinctin DD L inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 40 microM) [117]
                              Dermadistinctin DD M Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03147   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Dermadistinctin DD M inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 38 microM) [116]
                              Dermadistinctin DD Q1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03148   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Dermadistinctin DD Q1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 5.4 microM) [116]
                              Dermadistinctin DD Q2 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03149   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Dermadistinctin DD Q2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 22 microM) [116]
                              Dermaseptin BIII Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03156   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Dermaseptin BIII inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2.3 microM) [118]
                              Dermaseptin BIV Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03157   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Dermaseptin BIV inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 11.6 microM) [118]
                              Dermaseptin DPh-1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03152   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Dermaseptin DPh-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 6.6 microM) [119], [120]
                              Dermatoxin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03164   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Dermatoxin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [121]
                              Distinctin-2 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03197   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Distinctin-2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 28.0 microM) [122]
                              Drosophila cecropin-A1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03224   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Drosophila cecropin-A1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1-2.5 microM) [123], [124]
                              Drosophila cecropin-A1/A2 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03225   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Drosophila cecropin-A1/A2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2.2 microM) [123]
                              Drosophila cecropin-B Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03223   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Drosophila cecropin-B inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 4.2 microM) [125], [126]
                              Enterocin AS-48 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03251   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Enterocin AS-48 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [127]
                              Enterocin E-760 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03253   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Enterocin E-760 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [128]
                              Esculentin-1B Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03277   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Esculentin-1B inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 0.7 microM) [61]
                              Esculentin-2A Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03299   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Esculentin-2A inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 3.5 microM) [61]
                              Eumenine mastoparan-AF Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03362   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Eumenine mastoparan-AF inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 20 ug/ml) [129]
                              Eumenine mastoparan-EF Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03363   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Eumenine mastoparan-EF inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 30 microM) [130]
                              Eumenine mastoparan-ER Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03364   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Eumenine mastoparan-ER inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 30 microM) [130]
                              Eumenitin Er-12 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03366   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Eumenitin Er-12 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 30 microM) [131], [132]
                              Eumenitin F Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03367   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Eumenitin F inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 30 microM) [130]
                              Eumenitin R Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03368   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Eumenitin R inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 30 microM) [130]
                              Fish NRC-1 peptide Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04335   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Fish NRC-1 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 32 ug/ml) [133]
                              Fish NRC-10 peptide Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04336   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Fish NRC-10 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 32 ug/ml) [133]
                              Fish NRC-16 peptide Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04338   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Fish NRC-16 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1 ug/ml) [133]
                              Fish NRC-2 peptide Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04339   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Fish NRC-2 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 32 ug/ml) [133]
                              Fish NRC-3 peptide Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04340   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Fish NRC-3 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1 ug/ml) [133]
                              Flower-specific defensin NaD1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03396   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Flower-specific defensin NaD1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [134]
                              Fowlicidin-1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02734   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Fowlicidin-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 3.18 microM) [71]
                              Fowlicidin-2 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02736   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Fowlicidin-2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2.66 microM) [135]
                              Frog bombinin-like peptide BLP-1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02474   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Frog bombinin-like peptide BLP-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 6.3 microM) [53]
                              Frog defensin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03096   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Frog defensin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [69]
                              Fungus ribonuclease Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02301   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Fungus ribonuclease inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [136]
                              FV7 peptide Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03424   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation FV7 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [137]
                              Gaegurin-1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03436   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Gaegurin-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 50 ug/ml) [138]
                              Gaegurin-2 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03437   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Gaegurin-2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 50 ug/ml) [138]
                              Gaegurin-3 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03438   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Gaegurin-3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 50 ug/ml) [138]
                              Gaegurin-4 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03439   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Gaegurin-4 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 100 ug/ml) [139]
                              Gaegurin-5 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03440   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Gaegurin-5 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 100 ug/ml) [138]
                              Gaegurin-6 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03441   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Gaegurin-6 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 100 ug/ml) [138]
                              GGN4 analogue peptide D16W Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03052   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation GGN4 analogue peptide D16W inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 50 ug/ml) [140]
                              Gratisin analogue Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03508   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Gratisin analogue inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [141]
                              Hadrurin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03519   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Hadrurin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [142]
                              Hagfish HFIAP-1/2 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03556   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Hagfish HFIAP-1/2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 8 ug/ml) [143]
                              Hagfish HFIAP-3 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03557   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Hagfish HFIAP-3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 8 ug/ml) [143]
                              Halocidin subunit A Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03520   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Halocidin subunit A inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [144]
                              Halocidin subunit B Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03521   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Halocidin subunit B inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [144]
                              Halocyntin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03522   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Halocyntin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [145]
                              hBD-2 variant hPAB-beta Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03585   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation hBD-2 variant hPAB-beta inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 125 ug/ml) [146]
                              Heligoland antimicrobial peptide A Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04762   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Heligoland antimicrobial peptide A inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 12.5 microM) [147]
                              Hematopoietic antimicrobial MgCath37 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03540   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Hematopoietic antimicrobial MgCath37 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 8 ug/ml) [143]
                              Heteroscorpine-1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03549   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Heteroscorpine-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [148]
                              HFU3 peptide Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03558   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation HFU3 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 4 microM) [149]
                              HFU4 peptide Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03559   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation HFU4 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 4 microM) [149]
                              HFU5 peptide Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03560   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation HFU5 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 16 microM) [149]
                              Histone H5 derivative(71-90) Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04544   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Histone H5 derivative(71-90) inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 26.7 ug/ml) [150]
                              Histone H5 peptide derivative H5(61-90) Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03517   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Histone H5 peptide derivative H5(61-90) inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 16 ug/ml) [150]
                              HlMS-defensin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03573   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation HlMS-defensin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 37.5 ug/ml) [151]
                              HP(2-20) analogue Anal 1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02207   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation HP(2-20) analogue Anal 1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 3.13 ug/ml) [29]
                              HP(2-20) analogue Anal 2 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02208   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation HP(2-20) analogue Anal 2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 6.25 ug/ml) [29]
                              HP(2-20) analogue Anal 3 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02209   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation HP(2-20) analogue Anal 3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 3.13 ug/ml) [29]
                              HP(2-20) analogue Anal 4 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02210   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation HP(2-20) analogue Anal 4 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 12.5 ug/ml) [29]
                              HP(2-20) analogue Anal 5 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02211   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation HP(2-20) analogue Anal 5 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 12.5 ug/ml) [29]
                              HP(2-20) analogue Anal 6 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02212   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation HP(2-20) analogue Anal 6 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 6.25 ug/ml) [29]
                              HP(2-20) analogue Anal 7 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02213   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation HP(2-20) analogue Anal 7 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 3.13 ug/ml) [29]
                              Human beta-defensin hBD-2 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03588   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Human beta-defensin hBD-2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 62 ug/ml) [152]
                              Human beta-defensin hBD-28 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03591   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Human beta-defensin hBD-28 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 37.5 ug/ml) [153]
                              Human beta-defensin hBD-3 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03593   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Human beta-defensin hBD-3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 18.75 ug/ml) [153], [154]
                              Human beta-defensin hBD-4 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03594   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Human beta-defensin hBD-4 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 4.1 ug/ml) [155]
                              Human MUC7 20-Mer Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04146   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Human MUC7 20-Mer inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [156]
                              Hydramacin Hm-1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03609   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Hydramacin Hm-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [157], [158]
                              Hylaseptin-P1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03615   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Hylaseptin-P1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 48.8-64.0 ug/ml) [159]
                              Hylin-a1 Hy-a1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03616   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Hylin-a1 Hy-a1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 64 microM) [160]
                              Immune protein P9 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02769   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Immune protein P9 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1.9 microM) [161]
                              Indolicidin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03649   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Indolicidin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [162]
                              Indolicidin derivative chain a Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02820   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Indolicidin derivative chain a inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 16 ug/ml) [72]
                              Insect attacin-C Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02333   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Insect attacin-C inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 200 microM) [163]
                              Insect cecropin-A Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02768   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Insect cecropin-A inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 10-25 ug/ml) [164]
                              Insect cecropin-B Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02770   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Insect cecropin-B inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2.9 microM) [90], [165]
                              Insect cecropin-D Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02772   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Insect cecropin-D inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [161], [166]
                              Insect defensin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03098   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Insect defensin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 50 ug/ml) [167]
                              Insect defensin A Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03116   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Insect defensin A inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 40 microM) [168]
                              Insect polybia-MP-I Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04682   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Insect polybia-MP-I inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 5 microM) [169]
                              Insect polybia-MP-II Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04683   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Insect polybia-MP-II inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 38 microM) [169]
                              Insect polybia-MP-III Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04684   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Insect polybia-MP-III inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 310 microM) [169]
                              IsCT analog E7K [K7] Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO01820   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation IsCT analog E7K [K7] inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2 microM) [106]
                              IsCT analog K7,P8,K11 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO01819   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation IsCT analog K7,P8,K11 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2 microM) [106]
                              IsCT analog L6,K11 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO01821   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation IsCT analog L6,K11 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2 microM) [106]
                              IsCT analog W6A [A6] Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO01811   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation IsCT analog W6A [A6] inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 32 microM) [106]
                              IsCT analog W6L [L6] Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO01822   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation IsCT analog W6L [L6] inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 16 microM) [106]
                              Ixosin-B peptide derivative TSG-10 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05182   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Ixosin-B peptide derivative TSG-10 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 100 microM) [170]
                              Ixosin-B peptide derivative TSG-11 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05183   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Ixosin-B peptide derivative TSG-11 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 100 microM) [170]
                              Ixosin-B peptide derivative TSG-6 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05184   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Ixosin-B peptide derivative TSG-6 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 100 microM) [170]
                              Ixosin-B peptide derivative TSG-7 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05185   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Ixosin-B peptide derivative TSG-7 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 100 microM) [170]
                              Ixosin-B peptide derivative TSG-8 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05186   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Ixosin-B peptide derivative TSG-8 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 100 microM) [170]
                              Ixosin-B peptide derivative TSG-8-1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05187   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Ixosin-B peptide derivative TSG-8-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 100 microM) [170]
                              Ixosin-B peptide derivative TSG-9 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05188   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Ixosin-B peptide derivative TSG-9 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 100 microM) [170]
                              Jellein-1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03672   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Jellein-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 10 ug/ml) [171]
                              Jellein-2 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03673   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Jellein-2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 15 ug/ml) [171]
                              Jellein-3 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03674   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Jellein-3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 30 ug/ml) [172]
                              Jindongenin-1a Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03675   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Jindongenin-1a inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 23 microM) [173]
                              Kassinatuerin-1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03697   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Kassinatuerin-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 25 microM) [174], [175]
                              L-amino-acid oxidase Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03793   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation L-amino-acid oxidase inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 8 microM) [176]
                              L-amino-acid oxidase Oh-LAAO Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03797   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation L-amino-acid oxidase Oh-LAAO inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 0.2 microM) [177]
                              L5K5Wn model peptide L5K5W1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03746   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation L5K5Wn model peptide L5K5W1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 8 ug/ml) [178]
                              L5K5Wn model peptide L5K5W10 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03747   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation L5K5Wn model peptide L5K5W10 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 4 ug/ml) [178]
                              L5K5Wn model peptide L5K5W11 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03748   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation L5K5Wn model peptide L5K5W11 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 8 ug/ml) [178]
                              L5K5Wn model peptide L5K5W2 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03749   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation L5K5Wn model peptide L5K5W2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 8 ug/ml) [178]
                              L5K5Wn model peptide L5K5W3 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03750   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation L5K5Wn model peptide L5K5W3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 8 ug/ml) [178]
                              L5K5Wn model peptide L5K5W4 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03751   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation L5K5Wn model peptide L5K5W4 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 4 ug/ml) [178]
                              L5K5Wn model peptide L5K5W5 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03752   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation L5K5Wn model peptide L5K5W5 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 8 ug/ml) [178]
                              L5K5Wn model peptide L5K5W7 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03754   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation L5K5Wn model peptide L5K5W7 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 8 ug/ml) [178]
                              L5K5Wn model peptide L5K5W8 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03755   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation L5K5Wn model peptide L5K5W8 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 8 ug/ml) [178]
                              L5K5Wn model peptide L5K5W9 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03756   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation L5K5Wn model peptide L5K5W9 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 4 ug/ml) [178]
                              Lasioglossin III derivative LL-III Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03947   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Lasioglossin III derivative LL-III inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 22.5 microM) [179]
                              Lasioglossin LL-I derivative 1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03933   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Lasioglossin LL-I derivative 1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 22.7 microM) [179]
                              Lasioglossin LL-I derivative 2 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03934   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Lasioglossin LL-I derivative 2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 26.9 microM) [179]
                              Lasioglossin LL-I derivative 3 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03935   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Lasioglossin LL-I derivative 3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 19.0 microM) [179]
                              Lasioglossin LL-I derivative 4 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03936   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Lasioglossin LL-I derivative 4 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 100 microM) [179]
                              Lasioglossin LL-II derivative 1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03937   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Lasioglossin LL-II derivative 1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 23.3 microM) [179]
                              Lasioglossin LL-II derivative 2 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03938   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Lasioglossin LL-II derivative 2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 22.5 microM) [179]
                              Lasioglossin LL-II derivative 3 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03939   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Lasioglossin LL-II derivative 3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 26.1 microM) [179]
                              Lasioglossin LL-II derivative 4 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03940   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Lasioglossin LL-II derivative 4 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 100 microM) [179]
                              Lasioglossin LL-III derivative 1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03941   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Lasioglossin LL-III derivative 1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 23.1 microM) [179]
                              Lasioglossin LL-III derivative 2 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03943   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Lasioglossin LL-III derivative 2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 27.1 microM) [179]
                              Lasioglossin LL-III derivative 3 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03944   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Lasioglossin LL-III derivative 3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 26.1 microM) [179]
                              Lasioglossin LL-III derivative 4 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03945   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Lasioglossin LL-III derivative 4 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 100 microM) [179]
                              Lasioglossin LL-III derivative 7 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03948   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Lasioglossin LL-III derivative 7 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 75 microM) [179]
                              Lasioglossin LL-III derivative s-1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03950   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Lasioglossin LL-III derivative s-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 78.7 microM) [180]
                              Lasioglossin LL-III derivative s-2 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03951   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Lasioglossin LL-III derivative s-2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 86.7 microM) [180]
                              Lasioglossin LL-III derivative s-3 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03952   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Lasioglossin LL-III derivative s-3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 76.3 microM) [180]
                              Laterosporulin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03810   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Laterosporulin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [181]
                              Leptoglycin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03853   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Leptoglycin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 8 microM) [182]
                              Linear bactenecin bac2S-NH2 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03904   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Linear bactenecin bac2S-NH2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 16 ug/ml) [39]
                              Linear bactenecin bacS-NH2 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03905   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Linear bactenecin bacS-NH2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 16 ug/ml) [39]
                              LL-37(17-29) peptide Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03928   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation LL-37(17-29) peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 16 microM) [183], [184]
                              LlKmWn model peptide L4K3W4 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03739   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation LlKmWn model peptide L4K3W4 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 50 ug/ml) [185]
                              LlKmWn model peptide L5K3W5 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03744   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation LlKmWn model peptide L5K3W5 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 50 ug/ml) [185]
                              LlKmWn model peptide L5K5W6 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03753   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation LlKmWn model peptide L5K5W6 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 25 ug/ml) [185]
                              LlKmWn model peptide L6K4W6 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03759   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation LlKmWn model peptide L6K4W6 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 50 ug/ml) [185]
                              Lumbricin-PG Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02290   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Lumbricin-PG inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2.5 ug/ml) [186]
                              M-ctenitoxin-Cs1a Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04051   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation M-ctenitoxin-Cs1a inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 0.31-0.63 microM) [100], [187]
                              M-ctenitoxin-Cs1c Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04052   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation M-ctenitoxin-Cs1c inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [100]
                              M-ctenitoxin-Cs1d Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04053   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation M-ctenitoxin-Cs1d inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 0.16-0.31 microM) [100], [101]
                              M-lycotoxin-Ls3a Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04121   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation M-lycotoxin-Ls3a inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [188]
                              M-lycotoxin-Ls3b Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04122   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation M-lycotoxin-Ls3b inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 5.02-10.05 microM) [188]
                              M-theraphotoxin-Gr1a Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04142   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation M-theraphotoxin-Gr1a inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 8-16 microM) [189]
                              M-zodatoxin-Lt1a Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04177   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation M-zodatoxin-Lt1a inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 4.1 microM) [190], [191]
                              M-zodatoxin-Lt2a Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04178   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation M-zodatoxin-Lt2a inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 6.7 microM) [190], [192]
                              M-zodatoxin-Lt3a Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04179   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation M-zodatoxin-Lt3a inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 40 microM) [190]
                              M-zodatoxin-Lt3b Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04180   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation M-zodatoxin-Lt3b inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 45 microM) [190]
                              M-zodatoxin-Lt4a Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04181   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation M-zodatoxin-Lt4a inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 35 microM) [190]
                              M-zodatoxin-Lt4b Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04182   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation M-zodatoxin-Lt4b inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 35 microM) [190]
                              M-zodatoxin-Lt5a Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04183   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation M-zodatoxin-Lt5a inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 18 microM) [190]
                              M-zodatoxin-Lt8a Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04184   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation M-zodatoxin-Lt8a inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1.9 microM) [193]
                              M-zodatoxin-Lt8c Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04185   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation M-zodatoxin-Lt8c inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [193]
                              Magainin-2 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03985   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Magainin-2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 100 ug/ml) [194], [195]
                              Mammal mBMAP28 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04039   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Mammal mBMAP28 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 0.5 microM) [76]
                              Mastoparan MP-1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04000   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Mastoparan MP-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 8 ug/ml) [196]
                              Mastoparan MP-L Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04001   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Mastoparan MP-L inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 50 microM) [197]
                              Mastoparan-L [I5,R8] derivative Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO01816   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Mastoparan-L [I5,R8] derivative inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 6.25 microM) [197]
                              Melectin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04055   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Melectin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 18.5 microM) [198]
                              Melectin peptide MEP-N Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04061   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Melectin peptide MEP-N inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 17.3 microM) [180]
                              Melectin peptide MEP-Ns-1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04062   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Melectin peptide MEP-Ns-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 77 microM) [180]
                              Melittin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04057   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Melittin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 3 microM) [199]
                              Microcin L Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04114   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Microcin L inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [200], [201]
                              Modified defensin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04123   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Modified defensin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 4 ug/ml) [167]
                              Moricin-1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04128   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Moricin-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 0.81 microM) [202], [203]
                              Mucroporin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04149   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Mucroporin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 100 ug/ml) [204], [205]
                              Murine beta-defensin related peptide Defr1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03127   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Murine beta-defensin related peptide Defr1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [206]
                              Myeloid antimicrobial peptide BMAP-27 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04158   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Myeloid antimicrobial peptide BMAP-27 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1 microM) [76]
                              Myeloid antimicrobial peptide BMAP-28 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04159   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Myeloid antimicrobial peptide BMAP-28 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1 microM) [76]
                              Myticusin-1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04168   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Myticusin-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 25.0 microM) [207]
                              Myxinidin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04172   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Myxinidin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [208]
                              Neurokinin A Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04249   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Neurokinin A inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 500 ug/ml) [209]
                              Neutrophil cationic peptide 1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04256   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Neutrophil cationic peptide 1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [210], [211]
                              Neutrophil defensin HANP-1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04259   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Neutrophil defensin HANP-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [212]
                              Neutrophil defensin HANP-2 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04261   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Neutrophil defensin HANP-2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [212]
                              Neutrophil defensin HANP-3 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04265   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Neutrophil defensin HANP-3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [212]
                              Neutrophil defensin HANP-4 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04268   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Neutrophil defensin HANP-4 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [212]
                              Nigroain-B1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04276   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Nigroain-B1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 25.00 ug/ml) [213]
                              Nigroain-C2 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04277   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Nigroain-C2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 55.00 ug/ml) [213]
                              Nigroain-K2 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04281   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Nigroain-K2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 25.00 ug/ml) [213]
                              Nigrocin-OR1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04309   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Nigrocin-OR1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 7 microM) [214]
                              Non-disulfide-bridged peptide BmKb1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04540   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Non-disulfide-bridged peptide BmKb1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 90.8 ug/ml) [49], [215]
                              Novispirin G-10 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04333   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Novispirin G-10 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 0.11-12.7 ug/ml) [81]
                              Novispirin T-7 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04334   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Novispirin T-7 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 0.26-27.8 ug/ml) [81]
                              NRC-16 peptide Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04337   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation NRC-16 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [216]
                              Ocellatin-F1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04348   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Ocellatin-F1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 80 microM) [217]
                              Ocellatin-P1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04349   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Ocellatin-P1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 100 microM) [218]
                              Odorranain-F-OW1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04364   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Odorranain-F-OW1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 4 microM) [214]
                              Oh-defensin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04385   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Oh-defensin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 5 ug/ml) [219]
                              Opistoporin-1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04399   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Opistoporin-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 12.5 microM) [220]
                              Ovispirin-1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04416   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Ovispirin-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 0.7-5.6 ug/ml) [81]
                              Ovispirin-2 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04417   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Ovispirin-2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 0.03-16 ug/ml) [221]
                              Ovispirin-3 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04418   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Ovispirin-3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1-8 ug/ml) [221]
                              P18 analog N-1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04206   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation P18 analog N-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1.56 microM) [87]
                              P18 analog N-2 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04214   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation P18 analog N-2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1.56 microM) [87]
                              P18 analog N-3 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04216   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation P18 analog N-3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1.56 microM) [87]
                              P18 analog N-3L Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04218   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation P18 analog N-3L inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 3.125 microM) [87]
                              P18 analog N-4 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04219   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation P18 analog N-4 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1.56 microM) [87]
                              P18 analog N-4L Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04220   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation P18 analog N-4L inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1.56 microM) [87]
                              P18 analog N-5 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04221   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation P18 analog N-5 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 3.125 microM) [87]
                              P18 analog N-5L Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04222   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation P18 analog N-5L inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 3.125 microM) [87]
                              P18 analogue C-1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02663   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation P18 analogue C-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 6.25 microM) [87]
                              P18 analogue C-10 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02664   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation P18 analogue C-10 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 6.25-12.5 microM) [87]
                              P18 analogue C-2 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02672   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation P18 analogue C-2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 6.25 microM) [87]
                              P18 analogue C-3 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02673   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation P18 analogue C-3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 6.25 microM) [87]
                              P18 analogue C-4 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02674   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation P18 analogue C-4 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 6.25 microM) [87]
                              P18 analogue C-5 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02676   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation P18 analogue C-5 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 12.5 microM) [87]
                              P18 analogue C-6 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02677   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation P18 analogue C-6 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 6.25 microM) [87]
                              P18 analogue C-7 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02679   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation P18 analogue C-7 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 12.5 microM) [87]
                              P18 analogue C-8 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02680   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation P18 analogue C-8 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 6.25 microM) [87]
                              P18 analogue C-9 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02683   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation P18 analogue C-9 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 12.5 microM) [87]
                              P18 analogue L9 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO01823   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation P18 analogue L9 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 3.125 microM) [87]
                              P18 analogue S9 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO01825   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation P18 analogue S9 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 6.25 microM) [87]
                              Palustrin-2AJ1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04444   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Palustrin-2AJ1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 33 microM) [173]
                              Pandinin-1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04461   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Pandinin-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 20.8 microM) [222], [223]
                              Pandinin-2 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04462   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Pandinin-2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 38.2 microM) [224]
                              Paneth cell-specific alpha-defensin 1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04463   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Paneth cell-specific alpha-defensin 1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [225]
                              Papillosin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04468   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Papillosin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [145]
                              Parabutoporin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04471   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Parabutoporin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 6.3 microM) [226]
                              Pep-1 peptide derivative Pep-1-K Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04526   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Pep-1 peptide derivative Pep-1-K inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2.0 microM) [227]
                              Peptide D-LAK100 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03202   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Peptide D-LAK100 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 7.92 microM) [110]
                              Peptide D-LAK120 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03203   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Peptide D-LAK120 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2.71 microM) [110]
                              Peptide D-LAK120-A Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03204   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Peptide D-LAK120-A inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1.83 microM) [110]
                              Peptide D-LAK120-AP13 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03205   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Peptide D-LAK120-AP13 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1.22 microM) [110]
                              Peptide D-LAK120-H Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03206   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Peptide D-LAK120-H inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1.35 microM) [110]
                              Peptide D-LAK120-P13 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03207   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Peptide D-LAK120-P13 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1.42 microM) [110]
                              Peptide D-LAK140 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03208   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Peptide D-LAK140 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 4.69 microM) [110]
                              Peptide D-LAK160 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03209   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Peptide D-LAK160 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 6.23 microM) [110]
                              Peptide LAK120 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03781   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Peptide LAK120 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 4.20 microM) [110]
                              Peptide LAK120-P10 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03782   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Peptide LAK120-P10 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 9.16 microM) [110]
                              Peptide LAK120-P12 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03783   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Peptide LAK120-P12 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2.14 microM) [110]
                              Peptide LAK120-P7 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03784   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Peptide LAK120-P7 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 4.45 microM) [110]
                              Peptide LAK160 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03785   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Peptide LAK160 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2.23 microM) [110]
                              Peptide LAK160-P10 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03786   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Peptide LAK160-P10 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 4.14 microM) [110]
                              Peptide LAK160-P12 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03787   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Peptide LAK160-P12 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1.69 microM) [110]
                              Peptide LAK160-P7 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03788   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Peptide LAK160-P7 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2.98 microM) [110]
                              Peptide LAK80-P10 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03790   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Peptide LAK80-P10 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1.18 microM) [110]
                              Peptide LAK80-P12 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03791   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Peptide LAK80-P12 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 0.86 microM) [110]
                              Peptide LAK80-P7 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03792   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Peptide LAK80-P7 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2.13 microM) [110]
                              Peptide PMAP-36(1-20) Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04661   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Peptide PMAP-36(1-20) inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 3 microM) [228]
                              Perinerin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04546   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Perinerin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [229]
                              Phylloseptin PS-2 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04571   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Phylloseptin PS-2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa []
                              Phylloseptin PS-3 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04572   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Phylloseptin PS-3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [230], [231]
                              Phylloseptin PS-7 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04573   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Phylloseptin PS-7 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 6 microM) [119], [232]
                              Pilosulin 4 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04605   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Pilosulin 4 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC < 25 microM) [233]
                              Pilosulin Myr b I Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04606   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Pilosulin Myr b I inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 4 microM) [234]
                              Pilosulin P1(1-20) Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04426   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Pilosulin P1(1-20) inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 4 microM) [234]
                              Piscidin Pis-2 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04613   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Piscidin Pis-2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 5-10 microM) [235]
                              Plant JCpep7 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03671   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Plant JCpep7 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 64 ug/ml) [236]
                              Plant piceain 1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04601   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Plant piceain 1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 37.5 ug/ml) [237]
                              Plant piceain 2 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04602   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Plant piceain 2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 18.75 ug/ml) [237]
                              Pleurocidin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04640   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Pleurocidin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 35.0 microM) [238]
                              Pleurocidin-like peptide AP1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04642   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Pleurocidin-like peptide AP1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 32 ug/ml) [133]
                              Pleurocidin-like peptide AP2 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04643   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Pleurocidin-like peptide AP2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1 ug/ml) [133]
                              Pleurocidin-like peptide AP3 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04644   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Pleurocidin-like peptide AP3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1 ug/ml) [133]
                              Pleurocidin-like peptide GC3.2 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04645   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Pleurocidin-like peptide GC3.2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 64 ug/ml) [133]
                              Pleurocidin-like peptide GC3.8 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04646   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Pleurocidin-like peptide GC3.8 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2 ug/ml) [133]
                              Pleurocidin-like peptide GcSc4B7 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04647   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Pleurocidin-like peptide GcSc4B7 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 4 ug/ml) [133]
                              Pleurocidin-like peptide GcSc4C5 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04648   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Pleurocidin-like peptide GcSc4C5 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 32 ug/ml) [133]
                              Pleurocidin-like peptide Hb18 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04649   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Pleurocidin-like peptide Hb18 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 64 ug/ml) [133]
                              Pleurocidin-like peptide Hb26 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04650   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Pleurocidin-like peptide Hb26 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 32 ug/ml) [133]
                              Pleurocidin-like peptide WF3 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04651   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Pleurocidin-like peptide WF3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 32 ug/ml) [133], [239]
                              Pleurocidin-like peptide WF4 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04652   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Pleurocidin-like peptide WF4 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 16 ug/ml) [133], [239]
                              Pleurocidin-like peptide WFX Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04653   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Pleurocidin-like peptide WFX inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 64 ug/ml) [240]
                              Pleurocidin-like peptide WFY Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04654   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Pleurocidin-like peptide WFY inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 64 ug/ml) [240]
                              Pleurocidin-like peptide YT2 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04655   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Pleurocidin-like peptide YT2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2 ug/ml) [133]
                              PM1 linear derivative PM1-S Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04660   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation PM1 linear derivative PM1-S inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 32 ug/ml) [241]
                              Polyphemusin-1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04690   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Polyphemusin-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2 ug/ml) [242], [241]
                              Ponericin G1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04695   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Ponericin G1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [243]
                              Ponericin G3 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04696   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Ponericin G3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [243]
                              Ponericin G4 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04697   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Ponericin G4 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [243]
                              Ponericin G6 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04698   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Ponericin G6 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [243]
                              Ponericin-L2 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04699   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Ponericin-L2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [243]
                              Ponericin-W1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04700   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Ponericin-W1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [243]
                              Ponericin-W3 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04701   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Ponericin-W3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [243]
                              Ponericin-W4 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04702   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Ponericin-W4 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [243]
                              Ponericin-W5 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04703   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Ponericin-W5 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [243]
                              Ponericin-W6 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04704   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Ponericin-W6 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [243]
                              Pro-Gly Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04719   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Pro-Gly inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [244]
                              Protonectin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04737   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Protonectin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1.7 ug/ml) [4], [5]
                              PYLa/PGLa A chain PGLa Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04549   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation PYLa/PGLa A chain PGLa inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 250-500 ug/ml) [245], [30]
                              Ranalexin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04799   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Ranalexin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 128 ug/ml) [246], [247]
                              Ranalexin analog Del 1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03128   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Ranalexin analog Del 1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 256 ug/ml) [246]
                              Ranalexin analog Del 1-2 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03129   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Ranalexin analog Del 1-2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 256 ug/ml) [246]
                              Ranalexin analog Del 1-3 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03130   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Ranalexin analog Del 1-3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 256 ug/ml) [246]
                              Ranalexin analog Del 1-4 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03131   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Ranalexin analog Del 1-4 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 256 ug/ml) [246]
                              Ranalexin analog Del 20 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03132   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Ranalexin analog Del 20 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 128 ug/ml) [246]
                              Ranatuerin-2AUa Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04809   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Ranatuerin-2AUa inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 5 microM) [58]
                              Ranatuerin-2ZHa Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04827   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Ranatuerin-2ZHa inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 6 microM) [65]
                              Raniseptin-1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04837   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Raniseptin-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 10 microM) [248]
                              RTD peptide Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04863   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation RTD peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2.0 microM) [83]
                              Rugosin-A Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04865   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Rugosin-A inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 100 ug/ml) [249]
                              Rugosin-B Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04866   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Rugosin-B inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 100 ug/ml) [249]
                              S. litura moricin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04877   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation S. litura moricin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [250]
                              Single AA substitution D16F-N23 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03051   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Single AA substitution D16F-N23 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 200 ug/ml) [140]
                              Single AA substitution D16W-N23 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03053   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Single AA substitution D16W-N23 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 125 ug/ml) [140]
                              SMAP-29 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04954   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation SMAP-29 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [51]
                              SMAP-29 derivative A19 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO01810   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation SMAP-29 derivative A19 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 4.0 microM) [251]
                              SMAP-29 derivative K2,7,13 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO01817   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation SMAP-29 derivative K2,7,13 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 3.0 microM) [251]
                              SMAP-29 derivative K22,25,27 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO01818   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation SMAP-29 derivative K22,25,27 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 4.0 microM) [251]
                              SMAP-29 peptide derivative(1-17) Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04956   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation SMAP-29 peptide derivative(1-17) inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 16.0 microM) [251]
                              Snake OH-CATH peptide Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04384   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Snake OH-CATH peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2 ug/ml) [80]
                              Spheniscin-2 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04971   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Spheniscin-2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 6-12 microM) [252], [253]
                              Spider gomesin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03498   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Spider gomesin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1.6-3.15 microM) [33]
                              Spinigerin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04974   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Spinigerin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 50-100 microM) [254], [255]
                              Stomoxyn Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04995   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Stomoxyn inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 0.39-0.78 microM) [255], [256]
                              Styelin A Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04998   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Styelin A inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 4 ug/ml) [257]
                              Styelin B Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04999   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Styelin B inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 4.5 ug/ml) [257]
                              Substance P Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05006   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Substance P inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [258]
                              substance P antagonist Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05007   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation substance P antagonist inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [258]
                              Tachyplesin III Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05021   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Tachyplesin III inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [259]
                              Temporin-1Sa Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05063   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Temporin-1Sa inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 31 microM) [260]
                              Temporin-1Sc Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05065   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Temporin-1Sc inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 161 ug/ml) [260]
                              Temporin-1Va Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05073   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Temporin-1Va inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 160 microM) [261]
                              Temporin-1Vc Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05075   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Temporin-1Vc inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 160 microM) [261]
                              Temporin-A Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05076   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Temporin-A inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 360 microM) [262]
                              Temporin-B Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05085   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Temporin-B inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 360 microM) [262]
                              Temporin-RN1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05103   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Temporin-RN1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 4.7 ug/ml) [213]
                              Temporin-RN3 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05104   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Temporin-RN3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 3.75 ug/ml) [213]
                              Thanatin truncated isoform K18M(4-21) Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03681   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Thanatin truncated isoform K18M(4-21) inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 20-40 microM) [263]
                              Thuricin-S Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05139   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Thuricin-S inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [264]
                              Toad bombinin-like peptide BLP-1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02473   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Toad bombinin-like peptide BLP-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [265], [266]
                              Tracheal antimicrobial peptide Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05163   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Tracheal antimicrobial peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 25-50 ug/ml) [267], [268]
                              Tricystine cyclic cystine TP Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05170   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Tricystine cyclic cystine TP inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 5.0 microM) [83]
                              Tritrpticin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05179   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Tritrpticin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [269], [270]
                              Tritrpticin derivative TPA Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05161   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Tritrpticin derivative TPA inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 64 ug/ml) [271]
                              Tritrpticin derivative TPG Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05162   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Tritrpticin derivative TPG inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 64 ug/ml) [271]
                              Tritrpticin peptide derivative TWF Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05193   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Tritrpticin peptide derivative TWF inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 16 ug/ml) [271]
                              Trp- and Arg-rich peptide 2 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04532   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Trp- and Arg-rich peptide 2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [269]
                              V13KL peptide derivative A12L Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02104   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation V13KL peptide derivative A12L inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 24.8 ug/ml) [272]
                              V13KL peptide derivative A12L/A20L Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02105   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation V13KL peptide derivative A12L/A20L inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 125 ug/ml) [272], [273]
                              V13KL peptide derivative A12L/A23L Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02106   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation V13KL peptide derivative A12L/A23L inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 31.2 ug/ml) [272]
                              V13KL peptide derivative A20L Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02108   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation V13KL peptide derivative A20L inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 15.6 ug/ml) [272]
                              V13KL peptide derivative A23L Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02109   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation V13KL peptide derivative A23L inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 35.1 ug/ml) [272]
                              V681 peptide derivative S11AD Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04886   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation V681 peptide derivative S11AD inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 10.1 ug/ml) [274]
                              V681 peptide derivative S11G Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04880   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation V681 peptide derivative S11G inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 10.1 ug/ml) [274]
                              V681 peptide derivative V13G Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05212   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation V681 peptide derivative V13G inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 10.1 ug/ml) [274]
                              Xenopsin precursor fragment Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05303   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Xenopsin precursor fragment inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 125-250 ug/ml) [30]
      Health or Environmental Toxicant(s)
                  Acute Toxic Substance Click to Show/Hide the Full List of Xenobiotics:        3 Xenobiotics
                              Indole Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03644   XEOTIC Info Gene Form Protein
                                 Classification Acute Toxic Substance
                                 DME Modulation Indole inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [275]
                              para-ethylaniline Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04473   XEOTIC Info Gene Form Protein
                                 Classification Acute Toxic Substance
                                 DME Modulation para-ethylaniline inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [276]
                              Rosmarinic acid Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO01460   XEOTIC Info Gene Form Protein
                                 Classification Acute Toxic Substance
                                 DME Modulation Rosmarinic acid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [277]
                  Environmental Pollutant Click to Show/Hide the Full List of Xenobiotics:        5 Xenobiotics
                              6-Chlorooxindole Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02082   XEOTIC Info Gene Form Protein
                                 Classification Environmental Pollutant
                                 DME Modulation 6-Chlorooxindole inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [275]
                              Cis-2-dodecenoic acid Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02852   XEOTIC Info Gene Form Protein
                                 Classification Environmental Pollutant
                                 DME Modulation Cis-2-dodecenoic acid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [278]
                              Diphenyl disulphide Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03191   XEOTIC Info Gene Form Protein
                                 Classification Environmental Pollutant
                                 DME Modulation Diphenyl disulphide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [279]
                              Protocatechuic acid Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04736   XEOTIC Info Gene Form Protein
                                 Classification Environmental Pollutant
                                 DME Modulation Protocatechuic acid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [280]
                              Zinc oxide Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO01032   XEOTIC Info Gene Form Protein
                                 Classification Environmental Pollutant
                                 DME Modulation Zinc oxide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [281]
                  Health Hazard/Toxicant Click to Show/Hide the Full List of Xenobiotics:        6 Xenobiotics
                              4-chloroaniline Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02030   XEOTIC Info Gene Form Protein
                                 Classification Health and Environmental Toxicant
                                 DME Modulation 4-chloroaniline inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [276]
                              2-bromohexanoic acid Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO01938   XEOTIC Info Gene Form Protein
                                 Classification Health Hazard
                                 DME Modulation 2-bromohexanoic acid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [282]
                              7-nitroindole Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02098   XEOTIC Info Gene Form Protein
                                 Classification Health Hazard
                                 DME Modulation 7-nitroindole inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [283]
                              Caffeic acid Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO01232   XEOTIC Info Gene Form Protein
                                 Classification Health Hazard
                                 DME Modulation Caffeic acid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [284]
                              Coumarin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO00879   XEOTIC Info Gene Form Protein
                                 Classification Health Hazard
                                 DME Modulation Coumarin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [285]
                              Kojic acid Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO01357   XEOTIC Info Gene Form Protein
                                 Classification Health Hazard
                                 DME Modulation Kojic acid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [1]
      Natural Product(s), Extract(s) or Medicine(s)
                  Bacterial Extract Click to Show/Hide the Full List of Xenobiotics:      19 Xenobiotics
                              Actinomycetes NIO 10058 methanol extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04078   XEOTIC Info Gene Form Protein
                                 Classification Bacterial Extract
                                 DME Modulation Actinomycetes NIO 10058 methanol extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [244]
                              Actinomycetes NIO 10068 methanol extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04079   XEOTIC Info Gene Form Protein
                                 Classification Bacterial Extract
                                 DME Modulation Actinomycetes NIO 10068 methanol extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [244]
                              Actinomycetes NIO 10090 methanol extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04080   XEOTIC Info Gene Form Protein
                                 Classification Bacterial Extract
                                 DME Modulation Actinomycetes NIO 10090 methanol extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [244]
                              Bacillus aquimaris culture supernatant Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02986   XEOTIC Info Gene Form Protein
                                 Classification Bacterial Extract
                                 DME Modulation Bacillus aquimaris culture supernatant inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [286]
                              Bacillus arsenicus culture supernatant Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02987   XEOTIC Info Gene Form Protein
                                 Classification Bacterial Extract
                                 DME Modulation Bacillus arsenicus culture supernatant inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [286]
                              Bacillus cereus culture supernatant Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02988   XEOTIC Info Gene Form Protein
                                 Classification Bacterial Extract
                                 DME Modulation Bacillus cereus culture supernatant inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [286]
                              Bacillus indicus culture supernatant Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02989   XEOTIC Info Gene Form Protein
                                 Classification Bacterial Extract
                                 DME Modulation Bacillus indicus culture supernatant inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [286]
                              Bacillus niabensis culture supernatant Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03000   XEOTIC Info Gene Form Protein
                                 Classification Bacterial Extract
                                 DME Modulation Bacillus niabensis culture supernatant inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [286]
                              Bacillus pumilus culture supernatant Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03001   XEOTIC Info Gene Form Protein
                                 Classification Bacterial Extract
                                 DME Modulation Bacillus pumilus culture supernatant inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [286]
                              Bacillus sp. culture extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02974   XEOTIC Info Gene Form Protein
                                 Classification Bacterial Extract
                                 DME Modulation Bacillus sp. culture extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [287]
                              Coral associated bacteria extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02914   XEOTIC Info Gene Form Protein
                                 Classification Bacterial Extract
                                 DME Modulation Coral associated bacteria extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [288]
                              Cyclo(Trp-Ser) Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03037   XEOTIC Info Gene Form Protein
                                 Classification Bacterial Extract
                                 DME Modulation Cyclo(Trp-Ser) inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [289]
                              Enterobacter asburiae cell-free lysate Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02798   XEOTIC Info Gene Form Protein
                                 Classification Bacterial Extract
                                 DME Modulation Enterobacter asburiae cell-free lysate inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [290]
                              Ferrimonas balearica culture supernatant Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03002   XEOTIC Info Gene Form Protein
                                 Classification Bacterial Extract
                                 DME Modulation Ferrimonas balearica culture supernatant inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [286]
                              Halobacillus trueperi S6-09 culture supernatant Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03003   XEOTIC Info Gene Form Protein
                                 Classification Bacterial Extract
                                 DME Modulation Halobacillus trueperi S6-09 culture supernatant inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [286]
                              Halobacillus trueperi S6-16 culture supernatant Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03004   XEOTIC Info Gene Form Protein
                                 Classification Bacterial Extract
                                 DME Modulation Halobacillus trueperi S6-16 culture supernatant inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [286]
                              Marinobacter hydrocarbonoclasticus culture supernatant Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03007   XEOTIC Info Gene Form Protein
                                 Classification Bacterial Extract
                                 DME Modulation Marinobacter hydrocarbonoclasticus culture supernatant inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [286]
                              Paenibacillus strain culture extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02976   XEOTIC Info Gene Form Protein
                                 Classification Bacterial Extract
                                 DME Modulation Paenibacillus strain culture extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [291]
                              Staphylococcus pasteuri culture supernatant Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03008   XEOTIC Info Gene Form Protein
                                 Classification Bacterial Extract
                                 DME Modulation Staphylococcus pasteuri culture supernatant inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [286]
                  Natural Mixture Click to Show/Hide the Full List of Xenobiotics:        1 Xenobiotics
                              Flavonoids Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO00858   XEOTIC Info Gene Form Protein
                                 Classification Natural Mixture
                                 DME Modulation Flavonoids inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [292]
                  Natural Product Click to Show/Hide the Full List of Xenobiotics:      35 Xenobiotics
                              Aceroside VIII Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02123   XEOTIC Info Gene Form Protein
                                 Classification Natural Product
                                 DME Modulation Aceroside VIII inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [293]
                              Ajoene Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02152   XEOTIC Info Gene Form Protein
                                 Classification Natural Product
                                 DME Modulation Ajoene inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [294]
                              Anthranilate Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02235   XEOTIC Info Gene Form Protein
                                 Classification Natural Product
                                 DME Modulation Anthranilate inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [295]
                              Asperdiol Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02329   XEOTIC Info Gene Form Protein
                                 Classification Natural Product
                                 DME Modulation Asperdiol inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [296]
                              Baicalein Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO01212   XEOTIC Info Gene Form Protein
                                 Classification Natural Product
                                 DME Modulation Baicalein inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [280]
                              Betulin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO01221   XEOTIC Info Gene Form Protein
                                 Classification Natural Product
                                 DME Modulation Betulin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [297]
                              Chrysophanic acid Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO01528   XEOTIC Info Gene Form Protein
                                 Classification Natural Product
                                 DME Modulation Chrysophanic acid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [298]
                              Cinnamon oil Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02847   XEOTIC Info Gene Form Protein
                                 Classification Natural Product
                                 DME Modulation Cinnamon oil inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [299]
                              Clove oil Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO01531   XEOTIC Info Gene Form Protein
                                 Classification Natural Product
                                 DME Modulation Clove oil inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [300]
                              Crocin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02953   XEOTIC Info Gene Form Protein
                                 Classification Natural Product
                                 DME Modulation Crocin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [284]
                              Ephedrine Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03263   XEOTIC Info Gene Form Protein
                                 Classification Natural Product
                                 DME Modulation Ephedrine inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [280]
                              Fraxin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03403   XEOTIC Info Gene Form Protein
                                 Classification Natural Product
                                 DME Modulation Fraxin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [298]
                              Hyperoside Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03620   XEOTIC Info Gene Form Protein
                                 Classification Natural Product
                                 DME Modulation Hyperoside inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [301]
                              Indirubin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03642   XEOTIC Info Gene Form Protein
                                 Classification Natural Product
                                 DME Modulation Indirubin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [280]
                              Isatin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO00880   XEOTIC Info Gene Form Protein
                                 Classification Natural Product
                                 DME Modulation Isatin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [283]
                              knightine Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03710   XEOTIC Info Gene Form Protein
                                 Classification Natural Product
                                 DME Modulation knightine inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [296]
                              Malabaricone C Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03988   XEOTIC Info Gene Form Protein
                                 Classification Natural Product
                                 DME Modulation Malabaricone C inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [302]
                              Nodakenetin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04325   XEOTIC Info Gene Form Protein
                                 Classification Natural Product
                                 DME Modulation Nodakenetin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [298]
                              Pelargonidin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO01424   XEOTIC Info Gene Form Protein
                                 Classification Natural Product
                                 DME Modulation Pelargonidin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [303]
                              Penicillenol A1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04512   XEOTIC Info Gene Form Protein
                                 Classification Natural Product
                                 DME Modulation Penicillenol A1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [304]
                              Penicillenol A2 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04513   XEOTIC Info Gene Form Protein
                                 Classification Natural Product
                                 DME Modulation Penicillenol A2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [304]
                              Penicillenol B1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04514   XEOTIC Info Gene Form Protein
                                 Classification Natural Product
                                 DME Modulation Penicillenol B1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [304]
                              Penicillenol B2 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04515   XEOTIC Info Gene Form Protein
                                 Classification Natural Product
                                 DME Modulation Penicillenol B2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [304]
                              Penicillenol C1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04516   XEOTIC Info Gene Form Protein
                                 Classification Natural Product
                                 DME Modulation Penicillenol C1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [304]
                              Penicillenol C2 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04517   XEOTIC Info Gene Form Protein
                                 Classification Natural Product
                                 DME Modulation Penicillenol C2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [304]
                              Penicillic acid Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04518   XEOTIC Info Gene Form Protein
                                 Classification Natural Product
                                 DME Modulation Penicillic acid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [305]
                              Peppermint oil Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO01571   XEOTIC Info Gene Form Protein
                                 Classification Natural Product
                                 DME Modulation Peppermint oil inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [306]
                              Platyphylloside Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04629   XEOTIC Info Gene Form Protein
                                 Classification Natural Product
                                 DME Modulation Platyphylloside inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [293]
                              Psoralen Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04757   XEOTIC Info Gene Form Protein
                                 Classification Natural Product
                                 DME Modulation Psoralen inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [280]
                              Puag-haad Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO01442   XEOTIC Info Gene Form Protein
                                 Classification Natural Product
                                 DME Modulation Puag-haad inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [307]
                              Rutin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO01463   XEOTIC Info Gene Form Protein
                                 Classification Natural Product
                                 DME Modulation Rutin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [284]
                              Selenium nanoparticles Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04925   XEOTIC Info Gene Form Protein
                                 Classification Natural Product
                                 DME Modulation Selenium nanoparticles inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [308]
                              Shikonin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO01587   XEOTIC Info Gene Form Protein
                                 Classification Natural Product
                                 DME Modulation Shikonin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [298]
                              Vanillylacetone Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05227   XEOTIC Info Gene Form Protein
                                 Classification Natural Product
                                 DME Modulation Vanillylacetone inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [309]
                              Vitexin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05250   XEOTIC Info Gene Form Protein
                                 Classification Natural Product
                                 DME Modulation Vitexin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [310]
                  Parasite Extract Click to Show/Hide the Full List of Xenobiotics:        1 Xenobiotics
                              Rhipicephalus microplus egg-wax Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04852   XEOTIC Info Gene Form Protein
                                 Classification Parasite Extract
                                 DME Modulation Rhipicephalus microplus egg-wax inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [311]
                  Plant Extract Click to Show/Hide the Full List of Xenobiotics:      98 Xenobiotics
                              Agaricus blazei water extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05276   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Agaricus blazei water extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [312]
                              Azadirachta indica bark extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02393   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Azadirachta indica bark extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Azadirachta indica wood extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05288   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Azadirachta indica wood extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Blakea gracilis leaf extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03815   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Blakea gracilis leaf extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Burdock leaf ethanolic extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03349   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Burdock leaf ethanolic extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [314]
                              Cabralea canjerana bark extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02394   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Cabralea canjerana bark extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Capparis spinosa methanolic extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04089   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Capparis spinosa methanolic extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [315]
                              Carapa guianensis bark extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02395   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Carapa guianensis bark extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Carapa guianensis leaf extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03816   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Carapa guianensis leaf extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Carapa guianensis wood extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05289   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Carapa guianensis wood extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Carex arenicola extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04581   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Carex arenicola extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [307]
                              Carex boottiana extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04582   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Carex boottiana extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [307]
                              Carex dimorpholepis extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04583   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Carex dimorpholepis extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [307]
                              Carex humilis extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04584   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Carex humilis extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [307]
                              Carex lanceolata extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04585   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Carex lanceolata extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [307]
                              Carex pumila extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04586   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Carex pumila extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [307]
                              Carex scabrifolia extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04587   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Carex scabrifolia extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [307]
                              Carex siderosticta extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04588   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Carex siderosticta extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [307]
                              Cedrela fissilis bark extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02396   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Cedrela fissilis bark extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Cedrela fissilis leaf extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03817   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Cedrela fissilis leaf extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Cedrela odorata bark extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02397   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Cedrela odorata bark extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Cedrela odorata wood extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05290   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Cedrela odorata wood extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Cedrela salvadorensis bark extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02398   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Cedrela salvadorensis bark extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Cedrela tonduzii bark extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02399   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Cedrela tonduzii bark extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Cedrela tonduzii leaf extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03818   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Cedrela tonduzii leaf extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Cedrela tonduzii wood extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05291   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Cedrela tonduzii wood extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Chukrasia tabularis bark extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02400   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Chukrasia tabularis bark extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Chukrasia tabularis leaf extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03819   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Chukrasia tabularis leaf extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Chukrasia tabularis wood extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05292   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Chukrasia tabularis wood extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Clidemia dentata aerial part extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02139   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Clidemia dentata aerial part extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Conostegia rhodopetala leaf extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03822   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Conostegia rhodopetala leaf extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Cupania glabra bark extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02401   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Cupania glabra bark extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Cupania glabra leaf extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03823   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Cupania glabra leaf extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Cupania glabra wood extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05293   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Cupania glabra wood extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Dalbergia trichocarpa bark extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02402   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Dalbergia trichocarpa bark extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [316]
                              Dorema oil Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03218   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Dorema oil inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [317]
                              Equisetum hyemale crude extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02957   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Equisetum hyemale crude extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [318]
                              Ferula oil Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03389   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Ferula oil inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [317]
                              Garlic extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03472   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Garlic extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [319]
                              Ginger extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03482   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Ginger extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [320]
                              Guarea bullata leaf extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03824   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Guarea bullata leaf extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Guarea bullata stem extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04988   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Guarea bullata stem extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Guarea glabra bark extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02403   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Guarea glabra bark extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Guarea glabra leaf extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03825   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Guarea glabra leaf extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Guarea grandifolia bark extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02404   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Guarea grandifolia bark extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Guarea grandifolia leaf extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03826   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Guarea grandifolia leaf extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Guarea grandifolia stem extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04989   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Guarea grandifolia stem extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Guarea guidonia bark extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02405   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Guarea guidonia bark extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Guarea guidonia leaf extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03827   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Guarea guidonia leaf extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Guarea pterorhachis bark extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02406   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Guarea pterorhachis bark extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Guarea pterorhachis leaf extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03828   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Guarea pterorhachis leaf extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Guarea pyriformis bark extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02407   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Guarea pyriformis bark extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Herba patriniae extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03371   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Herba patriniae extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [321]
                              Kalanchoe blossfeldiana leaf methanol extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04084   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Kalanchoe blossfeldiana leaf methanol extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [322]
                              Lagerstroemia speciosa fruit extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03408   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Lagerstroemia speciosa fruit extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [323]
                              Leandra melanodesma leaf extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03829   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Leandra melanodesma leaf extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Leandra melanodesma stem extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04990   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Leandra melanodesma stem extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Mangifera indica leaf extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03830   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Mangifera indica leaf extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [324]
                              Miconia longifolia leaf extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03831   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Miconia longifolia leaf extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Miconia pittieri leaf extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03832   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Miconia pittieri leaf extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Miconia pittieri stem extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04991   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Miconia pittieri stem extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Ossaea brenesii aerial part extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02143   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Ossaea brenesii aerial part extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Peperomia vinasiana extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05286   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Peperomia vinasiana extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Piper bisasperatum aerial part extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02144   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Piper bisasperatum aerial part extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Piper decurrens leaf extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03833   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Piper decurrens leaf extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Piper pseudolindenii leaf extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03834   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Piper pseudolindenii leaf extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Piper reticulatum leaf extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03835   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Piper reticulatum leaf extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Piper urostachyum leaf extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03836   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Piper urostachyum leaf extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Piper urostachyum stem extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04992   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Piper urostachyum stem extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Ruptiliocarpon caracolito bark extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02408   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Ruptiliocarpon caracolito bark extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Ruptiliocarpon caracolito fruit extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03409   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Ruptiliocarpon caracolito fruit extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Ruptiliocarpon caracolito leaf extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03838   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Ruptiliocarpon caracolito leaf extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Ruptiliocarpon caracolito wood extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05294   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Ruptiliocarpon caracolito wood extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Simarouba amara leaf extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03839   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Simarouba amara leaf extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Simarouba glauca bark extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02409   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Simarouba glauca bark extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Simarouba glauca leaf extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03840   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Simarouba glauca leaf extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Swietenia macrophylla bark extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02410   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Swietenia macrophylla bark extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Swietenia macrophylla leaf extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03841   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Swietenia macrophylla leaf extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Swietenia macrophylla wood extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05295   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Swietenia macrophylla wood extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Swietenia mahogani bark extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02411   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Swietenia mahogani bark extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Swietenia mahogani leaf extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03842   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Swietenia mahogani leaf extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Swietenia mahogani wood extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05296   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Swietenia mahogani wood extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Syzygium aromaticum oil Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04386   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Syzygium aromaticum oil inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [325]
                              Terminalia chebula fruit extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03410   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Terminalia chebula fruit extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [326]
                              Thymus vulgaris ethanol extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03348   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Thymus vulgaris ethanol extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [327]
                              Thymus vulgaris methanol extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04087   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Thymus vulgaris methanol extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [327]
                              Toona ciliata wood extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05297   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Toona ciliata wood extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Trichilia glabra wood extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05298   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Trichilia glabra wood extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Trichilia martiana bark extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02413   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Trichilia martiana bark extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Trichilia martiana fruit extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03411   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Trichilia martiana fruit extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Trichilia martiana leaf extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03843   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Trichilia martiana leaf extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Trichilia pittieri stem extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04993   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Trichilia pittieri stem extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Trichilia pleeana bark extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02414   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Trichilia pleeana bark extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Trichilia pleeana leaf extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03844   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Trichilia pleeana leaf extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Trichilia pleeana wood extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05299   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Trichilia pleeana wood extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Trichilia septentrionalis leaf extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03845   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Trichilia septentrionalis leaf extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Trichilia septentrionalis wood extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05300   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Trichilia septentrionalis wood extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                              Trichilia trifolia wood extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05301   XEOTIC Info Gene Form Protein
                                 Classification Plant Extract
                                 DME Modulation Trichilia trifolia wood extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [313]
                  Sponge Extract Click to Show/Hide the Full List of Xenobiotics:        5 Xenobiotics
                              Amphimedon chloros sponge extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04975   XEOTIC Info Gene Form Protein
                                 Classification Sponge Extract
                                 DME Modulation Amphimedon chloros sponge extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [328]
                              Crella cyathophora sponge extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04976   XEOTIC Info Gene Form Protein
                                 Classification Sponge Extract
                                 DME Modulation Crella cyathophora sponge extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [328]
                              Diacarnus erythraenus sponge extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04977   XEOTIC Info Gene Form Protein
                                 Classification Sponge Extract
                                 DME Modulation Diacarnus erythraenus sponge extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [328]
                              Pione vastifica sponge extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04978   XEOTIC Info Gene Form Protein
                                 Classification Sponge Extract
                                 DME Modulation Pione vastifica sponge extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [328]
                              Sarcotragus sp sponge extract Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04979   XEOTIC Info Gene Form Protein
                                 Classification Sponge Extract
                                 DME Modulation Sarcotragus sp sponge extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [328]
      Pharmaceutical Agent(s)
                  Approved/Marketed Drug Click to Show/Hide the Full List of Xenobiotics:      31 Xenobiotics
                              Ampicillin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO00096   XEOTIC Info Gene Form Protein
                                 Classification Drug Approved by US FDA
                                 DME Modulation Ampicillin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [303]
                              Azithromycin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO00164   XEOTIC Info Gene Form Protein
                                 Classification Drug Approved by US FDA
                                 DME Modulation Azithromycin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [329]
                              Caffeine Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO00218   XEOTIC Info Gene Form Protein
                                 Classification Drug Approved by US FDA
                                 DME Modulation Caffeine inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [330]
                              Ceftazidime Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO00237   XEOTIC Info Gene Form Protein
                                 Classification Drug Approved by US FDA
                                 DME Modulation Ceftazidime inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [331]
                              Chlorpromazine Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02834   XEOTIC Info Gene Form Protein
                                 Classification Drug Approved by US FDA
                                 DME Modulation Chlorpromazine inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [332]
                              Ciprofloxacin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO00349   XEOTIC Info Gene Form Protein
                                 Classification Drug Approved by US FDA
                                 DME Modulation Ciprofloxacin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [333]
                              Colistin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02903   XEOTIC Info Gene Form Protein
                                 Classification Drug Approved by US FDA
                                 DME Modulation Colistin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [69]
                              Copper sulfate Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO00117   XEOTIC Info Gene Form Protein
                                 Classification Drug Approved by US FDA
                                 DME Modulation Copper sulfate inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [334]
                              Diclofenac sodium Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03184   XEOTIC Info Gene Form Protein
                                 Classification Drug Approved by US FDA
                                 DME Modulation Diclofenac sodium inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [335]
                              Dimethyl sulfoxide Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO00001   XEOTIC Info Gene Form Protein
                                 Classification Drug Approved by US FDA
                                 DME Modulation Dimethyl sulfoxide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [336]
                              Doripenem Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03219   XEOTIC Info Gene Form Protein
                                 Classification Drug Approved by US FDA
                                 DME Modulation Doripenem inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [69]
                              Doxycycline Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO00199   XEOTIC Info Gene Form Protein
                                 Classification Drug Approved by US FDA
                                 DME Modulation Doxycycline inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [337]
                              Fluorouracil Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO00037   XEOTIC Info Gene Form Protein
                                 Classification Drug Approved by US FDA
                                 DME Modulation Fluorouracil inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [338]
                              Gentamicin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO00396   XEOTIC Info Gene Form Protein
                                 Classification Drug Approved by US FDA
                                 DME Modulation Gentamicin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [339]
                              Hydrogen peroxide Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO00388   XEOTIC Info Gene Form Protein
                                 Classification Drug Approved by US FDA
                                 DME Modulation Hydrogen peroxide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [340]
                              Menthol Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO00416   XEOTIC Info Gene Form Protein
                                 Classification Drug Approved by US FDA
                                 DME Modulation Menthol inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [306]
                              Micafungin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04109   XEOTIC Info Gene Form Protein
                                 Classification Drug Approved by US FDA
                                 DME Modulation Micafungin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [341]
                              Niclosamide Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO00405   XEOTIC Info Gene Form Protein
                                 Classification Drug Approved by US FDA
                                 DME Modulation Niclosamide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [342]
                              Piperacillin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO00375   XEOTIC Info Gene Form Protein
                                 Classification Drug Approved by US FDA
                                 DME Modulation Piperacillin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [69]
                              Piperacillin-Tazobactam Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04611   XEOTIC Info Gene Form Protein
                                 Classification Drug Approved by US FDA
                                 DME Modulation Piperacillin-Tazobactam inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [259]
                              Streptomycin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04996   XEOTIC Info Gene Form Protein
                                 Classification Drug Approved by US FDA
                                 DME Modulation Streptomycin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [312]
                              Tobramycin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05156   XEOTIC Info Gene Form Protein
                                 Classification Drug Approved by US FDA
                                 DME Modulation Tobramycin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [343]
                              Toremifene Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05160   XEOTIC Info Gene Form Protein
                                 Classification Drug Approved by US FDA
                                 DME Modulation Toremifene inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [344]
                              Benzocaine Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02425   XEOTIC Info Gene Form Protein
                                 Classification Drug Marketed but not Approved by US FDA
                                 DME Modulation Benzocaine inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [276]
                              Catechin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO01239   XEOTIC Info Gene Form Protein
                                 Classification Drug Marketed but not Approved by US FDA
                                 DME Modulation Catechin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [345]
                              Cinnamic acid Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO01252   XEOTIC Info Gene Form Protein
                                 Classification Drug Marketed but not Approved by US FDA
                                 DME Modulation Cinnamic acid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [244]
                              Cynarin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03040   XEOTIC Info Gene Form Protein
                                 Classification Drug Marketed but not Approved by US FDA
                                 DME Modulation Cynarin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [284]
                              Silver nitrate Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO00511   XEOTIC Info Gene Form Protein
                                 Classification Drug Marketed but not Approved by US FDA
                                 DME Modulation Silver nitrate inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [334]
                              Sodium ascorbate Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04962   XEOTIC Info Gene Form Protein
                                 Classification Drug Marketed but not Approved by US FDA
                                 DME Modulation Sodium ascorbate inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [346]
                              Zinc chloride Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO00444   XEOTIC Info Gene Form Protein
                                 Classification Drug Marketed but not Approved by US FDA
                                 DME Modulation Zinc chloride inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [281]
                              Zinc sulfate Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO00460   XEOTIC Info Gene Form Protein
                                 Classification Drug Marketed but not Approved by US FDA
                                 DME Modulation Zinc sulfate inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [334]
                  Drug in Phase 3 Clinical Trial Click to Show/Hide the Full List of Xenobiotics:        2 Xenobiotics
                              Curcumin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO00683   XEOTIC Info Gene Form Protein
                                 Classification Highest Clinical Status: Phase 3
                                 DME Modulation Curcumin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [347]
                              Resveratrol Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO00568   XEOTIC Info Gene Form Protein
                                 Classification Highest Clinical Status: Phase 3
                                 DME Modulation Resveratrol inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [307]
                  Drug in Phase 2 Clinical Trial Click to Show/Hide the Full List of Xenobiotics:        4 Xenobiotics
                              Salicylic acid Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO00546   XEOTIC Info Gene Form Protein
                                 Classification Highest Clinical Status: Phase 2/3
                                 DME Modulation Salicylic acid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [348]
                              Delphinidin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO00619   XEOTIC Info Gene Form Protein
                                 Classification Highest Clinical Status: Phase 2
                                 DME Modulation Delphinidin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [303]
                              Lipoic acid Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03911   XEOTIC Info Gene Form Protein
                                 Classification Highest Clinical Status: Phase 2
                                 DME Modulation Lipoic acid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [1]
                              Ursolic acid Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO01496   XEOTIC Info Gene Form Protein
                                 Classification Highest Clinical Status: Phase 2
                                 DME Modulation Ursolic acid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [349]
                  Drug in Phase 1 Clinical Trial Click to Show/Hide the Full List of Xenobiotics:        8 Xenobiotics
                              Allicin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO01976   XEOTIC Info Gene Form Protein
                                 Classification Highest Clinical Status: Phase 1
                                 DME Modulation Allicin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [350]
                              Carvacrol Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO01237   XEOTIC Info Gene Form Protein
                                 Classification Highest Clinical Status: Phase 1
                                 DME Modulation Carvacrol inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [351]
                              Cyanidin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO01266   XEOTIC Info Gene Form Protein
                                 Classification Highest Clinical Status: Phase 1
                                 DME Modulation Cyanidin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [303]
                              Epsilon-viniferin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO00646   XEOTIC Info Gene Form Protein
                                 Classification Highest Clinical Status: Phase 1
                                 DME Modulation Epsilon-viniferin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [307]
                              L-tryptophan Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03968   XEOTIC Info Gene Form Protein
                                 Classification Highest Clinical Status: Phase 1
                                 DME Modulation L-tryptophan inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [295]
                              Naringenin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO00573   XEOTIC Info Gene Form Protein
                                 Classification Highest Clinical Status: Phase 1
                                 DME Modulation Naringenin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [316]
                              Palmitic acid Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO01420   XEOTIC Info Gene Form Protein
                                 Classification Highest Clinical Status: Phase 1
                                 DME Modulation Palmitic acid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [352]
                              Quercetin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO00538   XEOTIC Info Gene Form Protein
                                 Classification Highest Clinical Status: Phase 1
                                 DME Modulation Quercetin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [353]
                  Preclinical/Patented Drug Click to Show/Hide the Full List of Xenobiotics:        9 Xenobiotics
                              Baicalin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO00702   XEOTIC Info Gene Form Protein
                                 Classification Drug in Preclinical Study
                                 DME Modulation Baicalin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [280]
                              Emodin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO00692   XEOTIC Info Gene Form Protein
                                 Classification Drug in Preclinical Study
                                 DME Modulation Emodin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [298]
                              Esculetin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO01291   XEOTIC Info Gene Form Protein
                                 Classification Drug in Preclinical Study
                                 DME Modulation Esculetin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [280]
                              Oleic acid Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO01412   XEOTIC Info Gene Form Protein
                                 Classification Drug in Preclinical Study
                                 DME Modulation Oleic acid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [354]
                              5-fluoroindole Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02072   XEOTIC Info Gene Form Protein
                                 Classification Patented Pharmaceutical Agent
                                 DME Modulation 5-fluoroindole inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [283]
                              8-fluoroquinoline Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02100   XEOTIC Info Gene Form Protein
                                 Classification Patented Pharmaceutical Agent
                                 DME Modulation 8-fluoroquinoline inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [283]
                              Carbonyl cyanide m-chlorophenylhydrazone Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02713   XEOTIC Info Gene Form Protein
                                 Classification Patented Pharmaceutical Agent
                                 DME Modulation Carbonyl cyanide m-chlorophenylhydrazone inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [332]
                              Eugenol Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO00885   XEOTIC Info Gene Form Protein
                                 Classification Patented Pharmaceutical Agent
                                 DME Modulation Eugenol inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [355]
                              Ferulic acid Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO00730   XEOTIC Info Gene Form Protein
                                 Classification Patented Pharmaceutical Agent
                                 DME Modulation Ferulic acid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [280]
                  Investigative Agent Click to Show/Hide the Full List of Xenobiotics:      19 Xenobiotics
                              5-Chloroindole Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02069   XEOTIC Info Gene Form Protein
                                 Classification Investigative Agent
                                 DME Modulation 5-Chloroindole inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [275]
                              6-Gingerol Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02084   XEOTIC Info Gene Form Protein
                                 Classification Investigative Agent
                                 DME Modulation 6-Gingerol inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [356]
                              AL-1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO01872   XEOTIC Info Gene Form Protein
                                 Classification Investigative Agent
                                 DME Modulation AL-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [357]
                              Aseanostatin P5 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO01860   XEOTIC Info Gene Form Protein
                                 Classification Investigative Agent
                                 DME Modulation Aseanostatin P5 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [358]
                              Carboxymethyl chitosan Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02714   XEOTIC Info Gene Form Protein
                                 Classification Investigative Agent
                                 DME Modulation Carboxymethyl chitosan inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [334]
                              Esculin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03323   XEOTIC Info Gene Form Protein
                                 Classification Investigative Agent
                                 DME Modulation Esculin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [280]
                              Furanone C-30 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03415   XEOTIC Info Gene Form Protein
                                 Classification Investigative Agent
                                 DME Modulation Furanone C-30 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [338]
                              Furvina Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03422   XEOTIC Info Gene Form Protein
                                 Classification Investigative Agent
                                 DME Modulation Furvina inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [359]
                              Hamamelitannin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03523   XEOTIC Info Gene Form Protein
                                 Classification Investigative Agent
                                 DME Modulation Hamamelitannin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [343]
                              Isopentadecylic acid Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO01869   XEOTIC Info Gene Form Protein
                                 Classification Investigative Agent
                                 DME Modulation Isopentadecylic acid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [358]
                              Methyl gallate Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04106   XEOTIC Info Gene Form Protein
                                 Classification Investigative Agent
                                 DME Modulation Methyl gallate inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [360]
                              Myristic acid Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04162   XEOTIC Info Gene Form Protein
                                 Classification Investigative Agent
                                 DME Modulation Myristic acid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [352]
                              Norspermidine Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04331   XEOTIC Info Gene Form Protein
                                 Classification Investigative Agent
                                 DME Modulation Norspermidine inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [361]
                              p-Coumaric acid Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04482   XEOTIC Info Gene Form Protein
                                 Classification Investigative Agent
                                 DME Modulation p-Coumaric acid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [284]
                              Palmitoyl-DL-carnitine Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04438   XEOTIC Info Gene Form Protein
                                 Classification Investigative Agent
                                 DME Modulation Palmitoyl-DL-carnitine inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [352]
                              Pentagalloylglucose Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04522   XEOTIC Info Gene Form Protein
                                 Classification Investigative Agent
                                 DME Modulation Pentagalloylglucose inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [362]
                              Rhein Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO01455   XEOTIC Info Gene Form Protein
                                 Classification Investigative Agent
                                 DME Modulation Rhein inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [298]
                              Tannic acid Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05031   XEOTIC Info Gene Form Protein
                                 Classification Investigative Agent
                                 DME Modulation Tannic acid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [363]
                              Tricaine Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05167   XEOTIC Info Gene Form Protein
                                 Classification Investigative Agent
                                 DME Modulation Tricaine inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [276]
      Other Chemical Compound(s) or Element(s)
                  Food Additive Click to Show/Hide the Full List of Xenobiotics:        4 Xenobiotics
                              Furaneol Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02040   XEOTIC Info Gene Form Protein
                                 Classification Food Additive
                                 DME Modulation Furaneol inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [364]
                              Heptadecanoic acid Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03545   XEOTIC Info Gene Form Protein
                                 Classification Food Additive
                                 DME Modulation Heptadecanoic acid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [352]
                              Indole-3-carboxyaldehyde Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03647   XEOTIC Info Gene Form Protein
                                 Classification Food Additive
                                 DME Modulation Indole-3-carboxyaldehyde inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [283]
                              Zeaxanthin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05311   XEOTIC Info Gene Form Protein
                                 Classification Food Additive
                                 DME Modulation Zeaxanthin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [365]
                  Nanoparticle Click to Show/Hide the Full List of Xenobiotics:      11 Xenobiotics
                              Cadmium Ion Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02685   XEOTIC Info Gene Form Protein
                                 Classification Nanoparticle
                                 DME Modulation Cadmium Ion inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [281]
                              Chromate Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02836   XEOTIC Info Gene Form Protein
                                 Classification Nanoparticle
                                 DME Modulation Chromate inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [281]
                              Cobalt Ion Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02898   XEOTIC Info Gene Form Protein
                                 Classification Nanoparticle
                                 DME Modulation Cobalt Ion inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [281]
                              Ferrous Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03388   XEOTIC Info Gene Form Protein
                                 Classification Nanoparticle
                                 DME Modulation Ferrous inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [281]
                              Gallium cation Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03469   XEOTIC Info Gene Form Protein
                                 Classification Nanoparticle
                                 DME Modulation Gallium cation inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [281]
                              Platinum (IV) ion Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04628   XEOTIC Info Gene Form Protein
                                 Classification Nanoparticle
                                 DME Modulation Platinum (IV) ion inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [281]
                              Scandium carbonate Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04912   XEOTIC Info Gene Form Protein
                                 Classification Nanoparticle
                                 DME Modulation Scandium carbonate inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [281]
                              Silver Ion Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04940   XEOTIC Info Gene Form Protein
                                 Classification Nanoparticle
                                 DME Modulation Silver Ion inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [281]
                              Silver nanoparticle Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04941   XEOTIC Info Gene Form Protein
                                 Classification Nanoparticle
                                 DME Modulation Silver nanoparticle inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [366]
                              Tellurite Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05037   XEOTIC Info Gene Form Protein
                                 Classification Nanoparticle
                                 DME Modulation Tellurite inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [281]
                              Zinc Nitrate Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05315   XEOTIC Info Gene Form Protein
                                 Classification Nanoparticle
                                 DME Modulation Zinc Nitrate inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [281]
                  Chemical Compound Click to Show/Hide the Full List of Xenobiotics:      47 Xenobiotics
                              (Z)-4-bromo-5-(bromomethylene)-3-methylfuran-2(5H)-one Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO01804   XEOTIC Info Gene Form Protein
                                 Classification Chemical Compound
                                 DME Modulation (Z)-4-bromo-5-(bromomethylene)-3-methylfuran-2(5H)-one inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [367]
                              1-(4-amino-2-hydroxyphenyl)ethan-1-one Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO01832   XEOTIC Info Gene Form Protein
                                 Classification Chemical Compound
                                 DME Modulation 1-(4-amino-2-hydroxyphenyl)ethan-1-one inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [368]
                              1-(pyrazin-2-yl)ethan-1-one Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO01838   XEOTIC Info Gene Form Protein
                                 Classification Chemical Compound
                                 DME Modulation 1-(pyrazin-2-yl)ethan-1-one inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [368]
                              1-methanesulfonyl-4-methylbenzene Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO01879   XEOTIC Info Gene Form Protein
                                 Classification Chemical Compound
                                 DME Modulation 1-methanesulfonyl-4-methylbenzene inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [368]
                              2-Amino-5-acetylpyridine Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO01837   XEOTIC Info Gene Form Protein
                                 Classification Chemical Compound
                                 DME Modulation 2-Amino-5-acetylpyridine inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [368]
                              2-bromodecanoic acid Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO01937   XEOTIC Info Gene Form Protein
                                 Classification Chemical Compound
                                 DME Modulation 2-bromodecanoic acid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [282]
                              2-bromooctanoic acid Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO01939   XEOTIC Info Gene Form Protein
                                 Classification Chemical Compound
                                 DME Modulation 2-bromooctanoic acid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [282]
                              2-oxindole Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO01952   XEOTIC Info Gene Form Protein
                                 Classification Chemical Compound
                                 DME Modulation 2-oxindole inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [283]
                              3',5'-Dinitroacetophenone Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO01831   XEOTIC Info Gene Form Protein
                                 Classification Chemical Compound
                                 DME Modulation 3',5'-Dinitroacetophenone inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [368]
                              3,5-dimethylaniline Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO01975   XEOTIC Info Gene Form Protein
                                 Classification Chemical Compound
                                 DME Modulation 3,5-dimethylaniline inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [276]
                              3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO01961   XEOTIC Info Gene Form Protein
                                 Classification Chemical Compound
                                 DME Modulation 3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [369]
                              3-(Phenylsulfinyl)-L-alanine Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04973   XEOTIC Info Gene Form Protein
                                 Classification Chemical Compound
                                 DME Modulation 3-(Phenylsulfinyl)-L-alanine inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [279]
                              3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO01966   XEOTIC Info Gene Form Protein
                                 Classification Chemical Compound
                                 DME Modulation 3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [369]
                              3-fluoroaniline Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO01987   XEOTIC Info Gene Form Protein
                                 Classification Chemical Compound
                                 DME Modulation 3-fluoroaniline inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [276]
                              3-Indoleacetonitrile Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO01994   XEOTIC Info Gene Form Protein
                                 Classification Chemical Compound
                                 DME Modulation 3-Indoleacetonitrile inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [283]
                              4-Acetylpyridine Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO01839   XEOTIC Info Gene Form Protein
                                 Classification Chemical Compound
                                 DME Modulation 4-Acetylpyridine inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [368]
                              4-bromoaniline Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02026   XEOTIC Info Gene Form Protein
                                 Classification Chemical Compound
                                 DME Modulation 4-bromoaniline inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [276]
                              4-chloro-7-(trifluoromethyl)quinoline Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02029   XEOTIC Info Gene Form Protein
                                 Classification Chemical Compound
                                 DME Modulation 4-chloro-7-(trifluoromethyl)quinoline inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [370]
                              4-fluoroindole Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02036   XEOTIC Info Gene Form Protein
                                 Classification Chemical Compound
                                 DME Modulation 4-fluoroindole inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [283]
                              4-methanesulfonylaniline Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02042   XEOTIC Info Gene Form Protein
                                 Classification Chemical Compound
                                 DME Modulation 4-methanesulfonylaniline inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [368]
                              5-Bromoindole Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02065   XEOTIC Info Gene Form Protein
                                 Classification Chemical Compound
                                 DME Modulation 5-Bromoindole inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [275]
                              5-Chloro-1-(2-chloroacetyl)indoline-2,3-dione Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02068   XEOTIC Info Gene Form Protein
                                 Classification Chemical Compound
                                 DME Modulation 5-Chloro-1-(2-chloroacetyl)indoline-2,3-dione inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [371]
                              5-Methylisatin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO01829   XEOTIC Info Gene Form Protein
                                 Classification Chemical Compound
                                 DME Modulation 5-Methylisatin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [371]
                              6-Chloroindole Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02081   XEOTIC Info Gene Form Protein
                                 Classification Chemical Compound
                                 DME Modulation 6-Chloroindole inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [275]
                              6-fluoroindole Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02083   XEOTIC Info Gene Form Protein
                                 Classification Chemical Compound
                                 DME Modulation 6-fluoroindole inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [283]
                              7-bromoindole Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02089   XEOTIC Info Gene Form Protein
                                 Classification Chemical Compound
                                 DME Modulation 7-bromoindole inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [283]
                              7-chloroindole Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02090   XEOTIC Info Gene Form Protein
                                 Classification Chemical Compound
                                 DME Modulation 7-chloroindole inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [283]
                              7-fluoroindole Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02092   XEOTIC Info Gene Form Protein
                                 Classification Chemical Compound
                                 DME Modulation 7-fluoroindole inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [283]
                              7-Fluoroisatin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02093   XEOTIC Info Gene Form Protein
                                 Classification Chemical Compound
                                 DME Modulation 7-Fluoroisatin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [283]
                              7-formylindole Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02094   XEOTIC Info Gene Form Protein
                                 Classification Chemical Compound
                                 DME Modulation 7-formylindole inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [283]
                              7-hydroxyindole Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02095   XEOTIC Info Gene Form Protein
                                 Classification Chemical Compound
                                 DME Modulation 7-hydroxyindole inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [283]
                              7-methoxyindole Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02096   XEOTIC Info Gene Form Protein
                                 Classification Chemical Compound
                                 DME Modulation 7-methoxyindole inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [283]
                              7-methylindole Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02097   XEOTIC Info Gene Form Protein
                                 Classification Chemical Compound
                                 DME Modulation 7-methylindole inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [283]
                              Aminocyclopropane Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02188   XEOTIC Info Gene Form Protein
                                 Classification Chemical Compound
                                 DME Modulation Aminocyclopropane inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [276]
                              Aniline Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02228   XEOTIC Info Gene Form Protein
                                 Classification Chemical Compound
                                 DME Modulation Aniline inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [276]
                              Asperdiol acetate Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02330   XEOTIC Info Gene Form Protein
                                 Classification Chemical Compound
                                 DME Modulation Asperdiol acetate inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [296]
                              Cyclobutanamine Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03038   XEOTIC Info Gene Form Protein
                                 Classification Chemical Compound
                                 DME Modulation Cyclobutanamine inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [276]
                              Dibenzyl disulphide Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03179   XEOTIC Info Gene Form Protein
                                 Classification Chemical Compound
                                 DME Modulation Dibenzyl disulphide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [279]
                              Furanone Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03413   XEOTIC Info Gene Form Protein
                                 Classification Chemical Compound
                                 DME Modulation Furanone inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [372]
                              Indole-3-acetaldehyde Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03645   XEOTIC Info Gene Form Protein
                                 Classification Chemical Compound
                                 DME Modulation Indole-3-acetaldehyde inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [283]
                              Indole-7-carboxylic acid Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03648   XEOTIC Info Gene Form Protein
                                 Classification Chemical Compound
                                 DME Modulation Indole-7-carboxylic acid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [283]
                              meta-toluidine Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04073   XEOTIC Info Gene Form Protein
                                 Classification Chemical Compound
                                 DME Modulation meta-toluidine inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [276]
                              methanesulfonylbenzene Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04076   XEOTIC Info Gene Form Protein
                                 Classification Chemical Compound
                                 DME Modulation methanesulfonylbenzene inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [368]
                              Methyl indole-7-carboxylate Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04107   XEOTIC Info Gene Form Protein
                                 Classification Chemical Compound
                                 DME Modulation Methyl indole-7-carboxylate inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [283]
                              para-anisidine Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04469   XEOTIC Info Gene Form Protein
                                 Classification Chemical Compound
                                 DME Modulation para-anisidine inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [276]
                              para-toluidine Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04475   XEOTIC Info Gene Form Protein
                                 Classification Chemical Compound
                                 DME Modulation para-toluidine inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [276]
                              Pinguisenol Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04609   XEOTIC Info Gene Form Protein
                                 Classification Chemical Compound
                                 DME Modulation Pinguisenol inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa [373]
References
1 Inhibition of Pseudomonas aeruginosa biofilm formation by 2,2'-bipyridyl, lipoic, kojic and picolinic acids. Iran J Basic Med Sci. 2015 Aug;18(8):758-63.
2 A highly thermostable antimicrobial peptide from Aspergillus clavatus ES1: biochemical and molecular characterization. J Ind Microbiol Biotechnol. 2010 Aug;37(8):805-13.
3 Acylase-containing polyurethane coatings with anti-biofilm activity. Biotechnol Bioeng. 2016 Dec;113(12):2535-2543.
4 Structural and biological characterization of two novel peptides from the venom of the neotropical social wasp Agelaia pallipes pallipes. Toxicon. 2004 Jul;44(1):67-74.
5 Structural characterization of novel chemotactic and mastoparan peptides from the venom of the social wasp Agelaiapallipes pallipes by high-performance liquid chromatography/electrospray ionization tandem mass spectrometry. Rapid Commun Mass Spectrom. 2004;18(6):636-42.
6 Antibacterial activity of AI-hemocidin 2, a novel N-terminal peptide of hemoglobin purified from Arca inflata. Mar Drugs. 2017 Jun 29;15(7).
7 Cloning and functional characterization of a new antimicrobial peptide gene StCT1 from the venom of the scorpion Scorpiops tibetanus. Peptides. 2010 Jan;31(1):22-6.
8 StCT2, a new antibacterial peptide characterized from the venom of the scorpion Scorpiops tibetanus. Peptides. 2012 Aug;36(2):213-20.
9 Gene cloning and functional characterization of four novel antimicrobial-like peptides from scorpions of the family Vaejovidae. Peptides. 2012 Apr;34(2):290-5.
10 The andropin gene and its product, a male-specific antibacterial peptide in Drosophila melanogaster. EMBO J. 1991 Jan;10(1):163-9.
11 Cloning and analysis of a cecropin gene from the malaria vector mosquito, Anopheles gambiae. Insect Mol Biol. 2000 Feb;9(1):75-84.
12 Genomic organization and regulation of three cecropin genes in Anopheles gambiae. Insect Mol Biol. 2002 Dec;11(6):517-25.
13 Multiple isoforms of immune-related genes from hemocytes and eyestalk cDNA libraries of swimming crab Portunus trituberculatus. Fish Shellfish Immunol. 2011 Jul;31(1):29-42.
14 Molecular cloning, expression pattern and antimicrobial activity of a new isoform of anti-lipopolysaccharide factor from the swimming crab Portunus trituberculatus. Fish Shellfish Immunol. 2012 Jul;33(1):85-91.
15 A newly identified anti-lipopolysaccharide factor from the swimming crab Portunus trituberculatus with broad spectrum antimicrobial activity. Fish Shellfish Immunol. 2013 Feb;34(2):463-70.
16 Molecular cloning, genomic structure and antimicrobial activity of PtALF7, a unique isoform of anti-lipopolysaccharide factor from the swimming crab Portunus trituberculatus. Fish Shellfish Immunol. 2013 Feb;34(2):652-9.
17 Molecular cloning and chemical synthesis of a novel antibacterial peptide derived from pig myeloid cells. J Biol Chem. 1994 Mar 18;269(11):7855-8.
18 Chemical synthesis and biological activity of a novel antibacterial peptide deduced from a pig myeloid cDNA. FEBS Lett. 1994 Jan 17;337(3):303-7.
19 PMAP-37, a novel antibacterial peptide from pig myeloid cellscDNA cloning, chemical synthesis and activity. Eur J Biochem. 1995 Mar 15;228(3):941-6.
20 Evolution of the primate cathelicidinCorrelation between structural variations and antimicrobial activity. J Biol Chem. 2006 Jul 21;281(29):19861-71.
21 Amino acid sequence of PR-39Isolation from pig intestine of a new member of the family of proline-arginine-rich antibacterial peptides. Eur J Biochem. 1991 Dec 18;202(3):849-54.
22 Structure of the gene for porcine peptide antibiotic PR-39, a cathelin gene family member: comparative mapping of the locus for the human peptide antibiotic FALL-39. Proc Natl Acad Sci U S A. 1995 Jul 18;92(15):7085-9.
23 Identification and characterization of a bactericidal and proapoptotic peptide from Cycas revoluta seeds with DNA binding properties. J Cell Biochem. 2012 Jan;113(1):184-93.
24 Ginkbilobin, a novel antifungal protein from Ginkgo biloba seeds with sequence similarity to embryo-abundant protein. Biochem Biophys Res Commun. 2000 Dec 20;279(2):407-11.
25 Identification and structural insights of three novel antimicrobial peptides isolated from green coconut water. Peptides. 2009 Apr;30(4):633-7.
26 Identification of eNAP-1, an antimicrobial peptide from equine neutrophils. Infect Immun. 1992 Aug;60(8):3065-71.
27 eNAP-2, a novel cysteine-rich bactericidal peptide from equine leukocytes. Infect Immun. 1992 Dec;60(12):5042-7.
28 Selective inhibition of microbial serine proteases by eNAP-2, an antimicrobial peptide from equine neutrophils. Infect Immun. 1993 Jul;61(7):2991-4.
29 Interactions between the plasma membrane and the antimicrobial peptide HP (2-20) and its analogues derived from Helicobacter pylori. Biochem J. 2006 Feb 15;394(Pt 1):105-14.
30 Antimicrobial peptides in the stomach of Xenopus laevis. J Biol Chem. 1991 Oct 15;266(29):19851-7.
31 Antimicrobial peptides isolated from skin secretions of the diploid frog, Xenopus tropicalis (Pipidae). Biochim Biophys Acta. 2001 Nov 26;1550(1):81-9.
32 Purification and characterization of antibacterial proteins from granular hemocytes of Indian mud crab, Scylla serrata. Acta Biochim Pol. 2009;56(1):71-82.
33 Isolation and characterization of gomesin, an 18-residue cysteine-rich defense peptide from the spider Acanthoscurria gomesiana hemocytes with sequence similarities to horseshoe crab antimicrobial peptides of the tachyplesin family. J Biol Chem. 2000 Oct 27;275(43):33464-70.
34 Characterization of the venom from the Australian scorpion Urodacus yaschenkoi: Molecular mass analysis of components, cDNA sequences and peptides with antimicrobial activity. Toxicon. 2013 Mar 1;63:44-54.
35 The ascaphins: a family of antimicrobial peptides from the skin secretions of the most primitive extant frog, Ascaphus truei. Biochem Biophys Res Commun. 2004 Jul 16;320(1):170-5.
36 Sequence requirements and an optimization strategy for short antimicrobial peptides. Chem Biol. 2006 Oct;13(10):1101-7.
37 High-throughput generation of small antibacterial peptides with improved activity. Nat Biotechnol. 2005 Aug;23(8):1008-12.
38 Purification, composition, and activity of two bactenecins, antibacterial peptides of bovine neutrophils. Infect Immun. 1989 Oct;57(10):3142-6.
39 Improved derivatives of bactenecin, a cyclic dodecameric antimicrobial cationic peptide. Antimicrob Agents Chemother. 1999 May;43(5):1274-6.
40 Purification and properties of proline-rich antimicrobial peptides from sheep and goat leukocytes. Infect Immun. 1999 Aug;67(8):4106-11.
41 Characterization of anti-Legionella activity of warnericin RK and delta-lysin I from Staphylococcus warneri. Peptides. 2008 Jun;29(6):978-84.
42 Isolation of Lactobacillus salivarius 1077 (NRRL B-50053) and characterization of its bacteriocin, including the antimicrobial activity spectrum. Appl Environ Microbiol. 2011 Apr;77(8):2749-54.
43 Antibacterial activity of six novel peptides from Tityus discrepans scorpion venomA fluorescent probe study of microbial membrane Na+ permeability changes. Toxicon. 2009 Nov;54(6):802-17.
44 Identification and phylogenetic analysis of Tityus pachyurus and Tityus obscurus novel putative Na+-channel scorpion toxins. PLoS One. 2012;7(2):e30478.
45 The mouse genome encodes a single homolog of the antimicrobial peptide human beta-defensin 1. FEBS Lett. 1997 Aug 11;413(1):45-9.
46 Mouse beta-defensin 3 is an inducible antimicrobial peptide expressed in the epithelia of multiple organs. Infect Immun. 1999 Jul;67(7):3542-7.
47 Identification on mouse chromosome 8 of new beta-defensin genes with regionally specific expression in the male reproductive organ. J Biol Chem. 2004 Mar 26;279(13):12421-6.
48 Structure determination of human and murine beta-defensins reveals structural conservation in the absence of significant sequence similarity. Protein Sci. 2001 Dec;10(12):2470-9.
49 Identification and functional characterization of novel scorpion venom peptides with no disulfide bridge from Buthus martensii Karsch. Peptides. 2004 Feb;25(2):143-50.
50 Lactoferrin-derived peptides and Lactoferricin chimera inhibit virulence factor production and biofilm formation in Pseudomonas aeruginosa. J Appl Microbiol. 2010 Oct;109(4):1311-8.
51 Antibacterial and anti-biofilm effects of cathelicidin peptides against pathogens isolated from cystic fibrosis patients. Peptides. 2011 Sep;32(9):1807-14.
52 Antibacterial activity and mechanism of a scorpion venom peptide derivative in vitro and in vivo. PLoS One. 2012;7(7):e40135.
53 Bombinin-like peptides with antimicrobial activity from skin secretions of the Asian toad, Bombina orientalis. J Biol Chem. 1991 Dec 5;266(34):23103-11.
54 Structural organization of the bovine cathelicidin gene family and identification of a novel member. FEBS Lett. 1997 Nov 17;417(3):311-5.
55 Biological characterization of a novel mammalian antimicrobial peptide. Biochim Biophys Acta. 1998 Oct 23;1425(2):361-8.
56 Cloning and characterization of a novel cDNA sequence encoding the precursor of a novel venom peptide (BmKbpp) related to a bradykinin-potentiating peptide from Chinese scorpion Buthus martensii Karsch. IUBMB Life. 2000 Mar;49(3):207-10.
57 Characterization of BmKbpp, a multifunctional peptide from the Chinese scorpion Mesobuthus martensii Karsch: gaining insight into a new mechanism for the functional diversification of scorpion venom peptides. Peptides. 2012 Jan;33(1):44-51.
58 Host-defense peptides isolated from the skin secretions of the Northern red-legged frog Rana aurora aurora. Dev Comp Immunol. 2005;29(1):83-90.
59 Characterization of diverse antimicrobial peptides in skin secretions of Chungan torrent frog Amolops chunganensis. Peptides. 2012 Nov;38(1):41-53.
60 Novel antimicrobial peptides from skin secretion of the European frog Rana esculenta. FEBS Lett. 1993 Jun 14;324(2):159-61.
61 Antimicrobial peptides from skin secretions of Rana esculentaMolecular cloning of cDNAs encoding esculentin and brevinins and isolation of new active peptides. J Biol Chem. 1994 Apr 22;269(16):11956-61.
62 Structure-activity analysis of brevinin 1E amide, an antimicrobial peptide from Rana esculenta. Biochim Biophys Acta. 1998 Sep 8;1387(1-2):239-48.
63 Identification and characterization of antimicrobial peptides from skin of Amolops ricketti (Anura: Ranidae). Peptides. 2012 Jan;33(1):27-34.
64 Antimicrobial peptides from the skin of the Tsushima brown frog Rana tsushimensis. Comp Biochem Physiol C Toxicol Pharmacol. 2006 May;143(1):42-9.
65 Molecular cloning and functional characterization of novel antimicrobial peptides from the skin of brown frog, Rana zhenhaiensis. Zoolog Sci. 2012 Sep;29(9):553-8.
66 Two novel antimicrobial peptides from skin secretions of the frog, Rana nigrovittata. J Pept Sci. 2011 Jan;17(1):68-72.
67 Molecular cloning and characterization of antimicrobial peptides from skin of the broad-folded frog, Hylarana latouchii. Biochimie. 2012 Jun;94(6):1317-26.
68 Calcitermin, a novel antimicrobial peptide isolated from human airway secretions. FEBS Lett. 2001 Aug 24;504(1-2):5-10.
69 Inhibition and destruction of Pseudomonas aeruginosa biofilms by antibiotics and antimicrobial peptides. Peptides. 2014 Dec;62:32-7.
70 Characterization of a rabbit cationic protein (CAP18) with lipopolysaccharide-inhibitory activity. Infect Immun. 1994 Apr;62(4):1421-6.
71 Structure-activity relationships of fowlicidin-1, a cathelicidin antimicrobial peptide in chicken. FEBS J. 2006 Jun;273(12):2581-93.
72 Structure of the bovine antimicrobial peptide indolicidin bound to dodecylphosphocholine and sodium dodecyl sulfate micelles. Biochemistry. 2000 Dec 26;39(51):15765-74.
73 Structure-based design of an indolicidin peptide analogue with increased protease stability. Biochemistry. 2003 Dec 9;42(48):14130-8.
74 Bactericidal activity of mammalian cathelicidin-derived peptides. Infect Immun. 2000 May;68(5):2748-55.
75 Canine cathelicidin (K9CATH): gene cloning, expression, and biochemical activity of a novel pro-myeloid antimicrobial peptide. Dev Comp Immunol. 2007;31(12):1278-96.
76 Biological characterization of two novel cathelicidin-derived peptides and identification of structural requirements for their antimicrobial and cell lytic activities. J Biol Chem. 1996 Nov 8;271(45):28375-81.
77 Purification and structural characterization of bovine cathelicidins, precursors of antimicrobial peptides. Eur J Biochem. 1996 Jun 15;238(3):769-76.
78 Sequence analysis and polymorphism discovery in 4 members of the bovine cathelicidin gene family. J Hered. 2009 Mar-Apr;100(2):241-5.
79 Snake cathelicidin from Bungarus fasciatus is a potent peptide antibiotics. PLoS One. 2008 Sep 16;3(9):e3217.
80 Identification and characterization of novel reptile cathelicidins from elapid snakes. Peptides. 2008 Oct;29(10):1685-91.
81 Impact of single-residue mutations on the structure and function of ovispirin/novispirin antimicrobial peptides. Protein Eng. 2002 Mar;15(3):225-32.
82 Molecular analysis of the sheep cathelin family reveals a novel antimicrobial peptide. FEBS Lett. 1995 Dec 27;377(3):519-22.
83 Marked increase in membranolytic selectivity of novel cyclic tachyplesins constrained with an antiparallel two-beta strand cystine knot framework. Biochem Biophys Res Commun. 2000 Jan 27;267(3):783-90.
84 Shortened cecropin A-melittin hybridsSignificant size reduction retains potent antibiotic activity. FEBS Lett. 1992 Jan 20;296(2):190-4.
85 Mapping the orientation of helices in micelle-bound peptides by paramagnetic relaxation waves. J Am Chem Soc. 2007 Apr 25;129(16):5228-34.
86 Design, recombinant expression, and antibacterial activity of the cecropins-melittin hybrid antimicrobial peptides. Curr Microbiol. 2010 Sep;61(3):169-75.
87 Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs. J Pept Res. 2001 Dec;58(6):504-14.
88 Antibiotic activity of reversed peptides of alpha-helical antimicrobial peptide, P18. Protein Pept Lett. 2002 Oct;9(5):395-402.
89 Surface functionalization of titanium substrates with cecropin B to improve their cytocompatibility and reduce inflammation responses. Colloids Surf B Biointerfaces. 2013 Oct 1;110:225-35.
90 Insect immunity: isolation and structure of cecropins B and D from pupae of the Chinese oak silk moth, Antheraea pernyi. Eur J Biochem. 1982 Sep;127(1):219-24.
91 Cecropin P1 and novel nematode cecropins: a bacteria-inducible antimicrobial peptide family in the nematode Ascaris suum. Biochem J. 2005 Aug 15;390(Pt 1):207-14.
92 The structure of the mammalian antibacterial peptide cecropin P1 in solution, determined by proton-NMR. Eur J Biochem. 1992 Oct 1;209(1):163-9.
93 Biological properties of structurally related alpha-helical cationic antimicrobial peptides. Infect Immun. 1999 Apr;67(4):2005-9.
94 The genes encoding the antibacterial sex-specific peptides ceratotoxins are clustered in the genome of the medfly Ceratitis capitata. Insect Biochem Mol Biol. 1997 Dec;27(12):1039-46.
95 Discovery and characterization of novel cyclotides originated from chimeric precursors consisting of albumin-1 chain a and cyclotide domains in the Fabaceae family. J Biol Chem. 2011 Jul 8;286(27):24275-87.
96 The Design and Construction of K11: A Novel alpha-Helical Antimicrobial Peptide. Int J Microbiol. 2012;2012:764834.
97 Adaptation to phenylacetamide as a growth substrate by an acetanilide-utilizing mutant of Pseudomonas aeruginosa. Arch Microbiol. 1980 Apr;125(3):277-83.
98 Mechanism of action and relationship between structure and biological activity of Ctx-Ha: a new ceratotoxin-like peptide from Hypsiboas albopunctatus. Protein Pept Lett. 2012 Jun 1;19(6):596-603.
99 Novel Naja atra cardiotoxin 1 (CTX-1) derived antimicrobial peptides with broad spectrum activity. PLoS One. 2018 Jan 24;13(1):e0190778.
100 Cupiennin 1, a new family of highly basic antimicrobial peptides in the venom of the spider Cupiennius salei (Ctenidae). J Biol Chem. 2002 Mar 29;277(13):11208-16.
101 Characterisation of antibacterial activity of peptides isolated from the venom of the spider Cupiennius salei (Araneae: Ctenidae). Toxicon. 2000 Mar;38(3):373-80.
102 De novo design of potent antimicrobial peptides. Antimicrob Agents Chemother. 2004 Sep;48(9):3349-57.
103 Peptidomimetic antibiotics target outer-membrane biogenesis in Pseudomonas aeruginosa. Science. 2010 Feb 19;327(5968):1010-3.
104 An unusual structural motif of antimicrobial peptides containing end-to-end macrocycle and cystine-knot disulfides. Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):8913-8.
105 Cyclopsychotride A, a biologically active, 31-residue cyclic peptide isolated from Psychotria longipes. J Nat Prod. 1994 Dec;57(12):1619-25.
106 Antibiotic activity and structural analysis of the scorpion-derived antimicrobial peptide IsCT and its analogs. Biochem Biophys Res Commun. 2004 Oct 15;323(2):712-9.
107 IsCT, a novel cytotoxic linear peptide from scorpion Opisthacanthus madagascariensis. Biochem Biophys Res Commun. 2001 Aug 31;286(4):820-5.
108 Cell selectivity and anti-inflammatory activity of a Leu/Lys-rich alpha-helical model antimicrobial peptide and its diastereomeric peptides. Peptides. 2010 Jul;31(7):1251-61.
109 In vitro antibacterial properties of pexiganan, an analog of magainin. Antimicrob Agents Chemother. 1999 Apr;43(4):782-8.
110 Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic alpha-helical peptides. J Biol Chem. 2012 Oct 5;287(41):34120-33.
111 Purification and characterization of a vaterite-inducing peptide, pelovaterin, from the eggshells of Pelodiscus sinensis (Chinese soft-shelled turtle). Biomacromolecules. 2005 May-Jun;6(3):1429-37.
112 Structure, self-assembly, and dual role of a beta-defensin-like peptide from the Chinese soft-shelled turtle eggshell matrix. J Am Chem Soc. 2008 Apr 9;130(14):4660-8.
113 A novel defensin-like peptide from salivary glands of the hard tick, Haemaphysalis longicornis. Protein Sci. 2010 Mar;19(3):392-7.
114 Fabatins: new antimicrobial plant peptides. FEMS Microbiol Lett. 1997 Apr 1;149(1):59-64.
115 A defensin antimicrobial peptide from the venoms of Nasonia vitripennis. Toxicon. 2010 Aug 1;56(1):101-6.
116 Antimicrobial peptides from the Brazilian frog Phyllomedusa distincta. Peptides. 1999;20(6):679-86.
117 Dermaseptins from Phyllomedusa oreades and Phyllomedusa distincta: Secondary structure, antimicrobial activity, and mammalian cell toxicity. Comp Biochem Physiol A Mol Integr Physiol. 2008 Nov;151(3):336-43.
118 Structure, synthesis, and molecular cloning of dermaseptins B, a family of skin peptide antibiotics. J Biol Chem. 1998 Jun 12;273(24):14690-7.
119 Isolation and biochemical characterization of peptides presenting antimicrobial activity from the skin of Phyllomedusa hypochondrialis. Peptides. 2006 Dec;27(12):3092-9.
120 Novel dermaseptins from Phyllomedusa hypochondrialis (Amphibia). Biochem Biophys Res Commun. 2006 Sep 1;347(3):739-46.
121 Isolation of dermatoxin from frog skin, an antibacterial peptide encoded by a novel member of the dermaseptin genes family. Eur J Biochem. 2000 Jul;267(14):4583-92.
122 A novel heterodimeric antimicrobial peptide from the tree-frog Phyllomedusa distincta. FEBS Lett. 2001 Apr 6;494(1-2):85-9.
123 Molecular evolution of the Cecropin multigene family in Drosophilafunctional genes vspseudogenes. Genetics. 1998 Sep;150(1):157-71.
124 Evolutionary history and mechanism of the Drosophila cecropin gene family. Immunogenetics. 1998 May;47(6):417-29.
125 The cecropin locus in Drosophila; a compact gene cluster involved in the response to infection. EMBO J. 1990 Jan;9(1):217-24.
126 The immune response in Drosophila: pattern of cecropin expression and biological activity. EMBO J. 1990 Sep;9(9):2969-76.
127 Bactericidal and bacteriolytic action of peptide antibiotic AS-48 against gram-positive and gram-negative bacteria and other organisms. Res Microbiol. 1989 Jan;140(1):57-68.
128 Isolation and purification of enterocin E-760 with broad antimicrobial activity against gram-positive and gram-negative bacteria. Antimicrob Agents Chemother. 2008 Mar;52(3):1094-100.
129 Structure and biological activities of eumenine mastoparan-AF (EMP-AF), a new mast cell degranulating peptide in the venom of the solitary wasp (Anterhynchium flavomarginatum micado). Toxicon. 2000 Nov;38(11):1505-15.
130 Chemical and biological characterization of four new linear cationic alpha-helical peptides from the venoms of two solitary eumenine wasps. Toxicon. 2011 Jun;57(7-8):1081-92.
131 Eumenitin, a novel antimicrobial peptide from the venom of the solitary eumenine wasp Eumenes rubronotatus. Peptides. 2006 Nov;27(11):2624-31.
132 Effects of the cationic antimicrobial peptide eumenitin from the venom of solitary wasp Eumenes rubronotatus in planar lipid bilayers: surface charge and pore formation activity. Toxicon. 2008 Apr;51(5):736-45.
133 Novel antimicrobial peptides derived from flatfish genes. Antimicrob Agents Chemother. 2003 Aug;47(8):2464-70.
134 The plant defensin, NaD1, enters the cytoplasm of Fusarium oxysporum hyphae. J Biol Chem. 2008 May 23;283(21):14445-52.
135 CMAP27, a novel chicken cathelicidin-like antimicrobial protein. Vet Immunol Immunopathol. 2005 Jul 15;106(3-4):321-7.
136 A ribonuclease with antimicrobial, antimitogenic and antiproliferative activities from the edible mushroom Pleurotus sajor-caju. Peptides. 2004 Jan;25(1):11-7.
137 Design of embedded-hybrid antimicrobial peptides with enhanced cell selectivity and anti-biofilm activity. PLoS One. 2014 Jun 19;9(6):e98935.
138 Antimicrobial peptides from the skin of a Korean frog, Rana rugosa. Biochem Biophys Res Commun. 1994 Nov 30;205(1):948-54.
139 Solution structure and membrane interaction mode of an antimicrobial peptide gaegurin 4. Biochem Biophys Res Commun. 2007 Jan 19;352(3):592-7.
140 Effects of a tryptophanyl substitution on the structure and antimicrobial activity of C-terminally truncated gaegurin 4. Eur J Biochem. 2002 Sep;269(17):4367-74.
141 A novel polycationic analogue of gratisin with antibiotic activity against both Gram-positive and Gram-negative bacteria. J Antibiot (Tokyo). 2008 Jan;61(1):33-5.
142 Hadrurin, a new antimicrobial peptide from the venom of the scorpion Hadrurus aztecus. Eur J Biochem. 2000 Aug;267(16):5023-31.
143 Hagfish intestinal antimicrobial peptides are ancient cathelicidins. Peptides. 2003 Nov;24(11):1655-67.
144 Halocidin: a new antimicrobial peptide from hemocytes of the solitary tunicate, Halocynthia aurantium. FEBS Lett. 2002 Jun 19;521(1-3):81-6.
145 Halocyntin and papillosin, two new antimicrobial peptides isolated from hemocytes of the solitary tunicate, Halocynthia papillosa. J Pept Sci. 2009 Jan;15(1):48-55.
146 Design and expression of peptide antibiotic hPAB-beta as tandem multimers in Escherichia coli. Peptides. 2005 May;26(5):721-9.
147 A reverse search for antimicrobial peptides in Ciona intestinalis: identification of a gene family expressed in hemocytes and evaluation of activity. Dev Comp Immunol. 2008;32(3):286-98.
148 Purification and characterization of Heteroscorpine-1 (HS-1) toxin from Heterometrus laoticus scorpion venom. Toxicon. 2007 Jan;49(1):19-29.
149 Biochemical property and membrane-peptide interactions of de novo antimicrobial peptides designed by helix-forming units. Amino Acids. 2012 Dec;43(6):2527-36.
150 Histone H5 is a potent antimicrobial agent and a template for novel antimicrobial peptides. Sci Rep. 2018 Feb 5;8(1):2411.
151 Cloning and characterization of a male-specific defensin-like antimicrobial peptide from the tick Haemaphysalis longicornis. Dev Comp Immunol. 2012 May;37(1):207-11.
152 A peptide antibiotic from human skin. Nature. 1997 Jun 26;387(6636):861.
153 Engineering disulfide bonds of the novel human beta-defensins hBD-27 and hBD-28: differences in disulfide formation and biological activity among human beta-defensins. Biopolymers. 2005;80(1):34-49.
154 Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic. J Biol Chem. 2001 Feb 23;276(8):5707-13.
155 Human beta-defensin 4: a novel inducible peptide with a specific salt-sensitive spectrum of antimicrobial activity. FASEB J. 2001 Aug;15(10):1819-21.
156 MUC7 20-Mer: investigation of antimicrobial activity, secondary structure, and possible mechanism of antifungal action. Antimicrob Agents Chemother. 2003 Feb;47(2):643-52.
157 Uncovering the evolutionary history of innate immunity: the simple metazoan Hydra uses epithelial cells for host defence. Dev Comp Immunol. 2009 Apr;33(4):559-69.
158 Hydramacin-1, structure and antibacterial activity of a protein from the basal metazoan Hydra. J Biol Chem. 2009 Jan 16;284(3):1896-905.
159 The NMR-derived solution structure of a new cationic antimicrobial peptide from the skin secretion of the anuran Hyla punctata. J Biol Chem. 2004 Mar 26;279(13):13018-26.
160 Hylin a1, the first cytolytic peptide isolated from the arboreal South American frog Hypsiboas albopunctatus ("spotted treefrog"). Peptides. 2009 Feb;30(2):291-6.
161 Insect immunity: isolation and structure of cecropin D and four minor antibacterial components from Cecropia pupae. Eur J Biochem. 1982 Sep;127(1):207-17.
162 Human host defense peptide LL-37 prevents bacterial biofilm formation. Infect Immun. 2008 Sep;76(9):4176-82.
163 Primary structure and in vitro antibacterial properties of the Drosophila melanogaster attacin C Pro-domain. J Biol Chem. 2004 Apr 9;279(15):14853-9.
164 Antimicrobial activity spectrum, cDNA cloning, and mRNA expression of a newly isolated member of the cecropin family from the mosquito vector Aedes aegypti. J Biol Chem. 1999 Jul 16;274(29):20092-7.
165 Plasma desorption mass spectrometry coupled with conventional peptide sequencing techniques. Biomed Environ Mass Spectrom. 1987 Nov;14(11):669-73.
166 The cecropin locusCloning and expression of a gene cluster encoding three antibacterial peptides in Hyalophora cecropia. J Biol Chem. 1991 Jun 25;266(18):11510-7.
167 Purification, cDNA cloning and modification of a defensin from the coconut rhinoceros beetle, Oryctes rhinoceros. Eur J Biochem. 1999 Dec;266(2):616-23.
168 Two novel insect defensins from larvae of the cupreous chafer, Anomala cuprea: purification, amino acid sequences and antibacterial activity. Insect Biochem Mol Biol. 2001 Dec;32(1):75-84.
169 Characterization of two novel polyfunctional mastoparan peptides from the venom of the social wasp Polybia paulista. Peptides. 2009 Aug;30(8):1387-95.
170 Structure-activity relationship of potent antimicrobial peptide analogs of Ixosin-B amide. Bioorg Med Chem Lett. 2013 May 15;23(10):2929-32.
171 Change in the mode of gene expression of the hypopharyngeal gland cells with an age-dependent role change of the worker honeybee Apis mellifera L. Eur J Biochem. 1997 Nov 1;249(3):797-802.
172 Jelleines: a family of antimicrobial peptides from the Royal Jelly of honeybees (Apis mellifera). Peptides. 2004 Jun;25(6):919-28.
173 Two novel families of antimicrobial peptides from skin secretions of the Chinese torrent frog, Amolops jingdongensis. Biochimie. 2012 Feb;94(2):328-34.
174 Kassinatuerin-1: a peptide with broad-spectrum antimicrobial activity isolated from the skin of the hyperoliid frog, Kassina senegalensis. Biochem Biophys Res Commun. 2000 Feb 16;268(2):433-6.
175 Antimicrobial and cytolytic properties of the frog skin peptide, kassinatuerin-1 and its L- and D-lysine-substituted derivatives. Peptides. 2005 Nov;26(11):2104-10.
176 Evaluation of an antimicrobial L-amino acid oxidase and peptide derivatives from Bothropoides mattogrosensis pitviper venom. PLoS One. 2012;7(3):e33639.
177 Antibacterial action of a heat-stable form of L-amino acid oxidase isolated from king cobra (Ophiophagus hannah) venom. Comp Biochem Physiol C Toxicol Pharmacol. 2011 Mar;153(2):237-42.
178 Structural characterization of de novo designed L5K5W model peptide isomers with potent antimicrobial and varied hemolytic activities. Molecules. 2013 Jan 11;18(1):859-76.
179 Lasioglossins: three novel antimicrobial peptides from the venom of the eusocial bee Lasioglossum laticeps (Hymenoptera: Halictidae). Chembiochem. 2009 Aug 17;10(12):2089-99.
180 Effect of hydrocarbon stapling on the properties of alpha-helical antimicrobial peptides isolated from the venom of hymenoptera. Amino Acids. 2012 Nov;43(5):2047-58.
181 Identification, purification and characterization of laterosporulin, a novel bacteriocin produced by Brevibacillus spstrain GI-9. PLoS One. 2012;7(3):e31498.
182 Leptoglycin: a new Glycine/Leucine-rich antimicrobial peptide isolated from the skin secretion of the South American frog Leptodactylus pentadactylus (Leptodactylidae). Toxicon. 2009 Jul;54(1):23-32.
183 High specific selectivity and membrane-active mechanism of synthetic cationic hybrid antimicrobial peptides based on the peptide FV7. Int J Mol Sci. 2017 Feb 6;18(2).
184 Solution structures of human LL-37 fragments and NMR-based identification of a minimal membrane-targeting antimicrobial and anticancer region. J Am Chem Soc. 2006 May 3;128(17):5776-85.
185 De novo generation of antimicrobial LK peptides with a single tryptophan at the critical amphipathic interface. J Pept Sci. 2009 Sep;15(9):583-8.
186 A novel antimicrobial peptide from skin secretions of the earthworm, Pheretima guillelmi (Michaelsen). Peptides. 2011 Jun;32(6):1146-50.
187 Solution structure and interaction of cupiennin 1a, a spider venom peptide, with phospholipid bilayers. Biochemistry. 2007 Mar 20;46(11):3576-85.
188 De novo sequencing of antimicrobial peptides isolated from the venom glands of the wolf spider Lycosa singoriensis. J Mass Spectrom. 2004 Feb;39(2):193-201.
189 Identification of a peptide toxin from Grammostola spatulata spider venom that blocks cation-selective stretch-activated channels. J Gen Physiol. 2000 May;115(5):583-98.
190 Latarcins, antimicrobial and cytolytic peptides from the venom of the spider Lachesana tarabaevi (Zodariidae) that exemplify biomolecular diversity. J Biol Chem. 2006 Jul 28;281(30):20983-92.
191 Three-dimensional structure/hydrophobicity of latarcins specifies their mode of membrane activity. Biochemistry. 2008 Mar 18;47(11):3525-33.
192 Spatial structure and activity mechanism of a novel spider antimicrobial peptide. Biochemistry. 2006 Sep 5;45(35):10759-67.
193 Cyto-insectotoxins, a novel class of cytolytic and insecticidal peptides from spider venom. Biochem J. 2008 May 1;411(3):687-96.
194 Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc Natl Acad Sci U S A. 1987 Aug;84(15):5449-53.
195 Two-dimensional 1H NMR experiments show that the 23-residue magainin antibiotic peptide is an alpha-helix in dodecylphosphocholine micelles, sodium dodecylsulfate micelles, and trifluoroethanol/water solution. J Biomol NMR. 1997 Feb;9(2):127-35.
196 Structural and functional characterization of two novel peptide toxins isolated from the venom of the social wasp Polybia paulista. Peptides. 2005 Nov;26(11):2157-64.
197 Selective amino acid substitution reduces cytotoxicity of the antimicrobial peptide mastoparan. Biochim Biophys Acta. 2016 Nov;1858(11):2699-2708.
198 Melectin: a novel antimicrobial peptide from the venom of the cleptoparasitic bee Melecta albifrons. Chembiochem. 2008 Nov 24;9(17):2815-21.
199 Identification of a novel melittin isoform from Africanized Apis mellifera venom. Peptides. 2010 Aug;31(8):1473-9.
200 Genetic analysis and complete primary structure of microcin L. Antimicrob Agents Chemother. 2004 Feb;48(2):505-13.
201 Wild-type Escherichia coli producing microcins B17, D93, J25, and L; cloning of genes for microcin L production and immunity. Can J Microbiol. 2003 May;49(5):357-61.
202 Moricin, a novel type of antibacterial peptide isolated from the silkworm, Bombyx mori. J Biol Chem. 1995 Dec 15;270(50):29923-7.
203 Solution structure of moricin, an antibacterial peptide, isolated from the silkworm Bombyx mori. FEBS Lett. 2002 May 8;518(1-3):33-8.
204 Comparative venom gland transcriptome analysis of the scorpion Lychas mucronatus reveals intraspecific toxic gene diversity and new venomous components. BMC Genomics. 2010 Jul 28;11:452.
205 Mucroporin, the first cationic host defense peptide from the venom of Lychas mucronatus. Antimicrob Agents Chemother. 2008 Nov;52(11):3967-72.
206 Identification and characterization of a novel murine beta-defensin-related gene. Mamm Genome. 2002 Aug;13(8):445-51.
207 Molecular characterization of a novel antimicrobial peptide from Mytilus coruscus. Fish Shellfish Immunol. 2013 Feb;34(2):610-6.
208 Myxinidin, a novel antimicrobial peptide from the epidermal mucus of hagfish, Myxine glutinosa L. Mar Biotechnol (NY). 2009 Nov-Dec;11(6):748-57.
209 Antimicrobial activity of neuropeptides against a range of micro-organisms from skin, oral, respiratory and gastrointestinal tract sites. J Neuroimmunol. 2008 Aug 30;200(1-2):11-6.
210 Purification, primary structure, and biological activity of guinea pig neutrophil cationic peptides. Infect Immun. 1989 Aug;57(8):2405-9.
211 Purification, primary structure, and antimicrobial activities of a guinea pig neutrophil defensin. Infect Immun. 1987 Sep;55(9):2281-6.
212 Isolation, antimicrobial activities, and primary structures of hamster neutrophil defensins. Infect Immun. 1996 Nov;64(11):4444-9.
213 Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata. Genomics. 2010 Jan;95(1):66-71.
214 Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs. J Proteome Res. 2012 Jan 1;11(1):306-19.
215 Genomic organization of four novel nondisulfide-bridged peptides from scorpion Mesobuthus martensii Karsch: gaining insight into evolutionary mechanism. Peptides. 2005 Dec;26(12):2427-33.
216 Anti-microbial, anti-biofilm activities and cell selectivity of the NRC-16 peptide derived from witch flounder, Glyptocephalus cynoglossus. Mar Drugs. 2013 May 28;11(6):1836-52.
217 An antimicrobial peptide from the skin secretions of the mountain chicken frog Leptodactylus fallax (Anura:Leptodactylidae). Regul Pept. 2005 Jan 15;124(1-3):173-8.
218 Pentadactylin: an antimicrobial peptide from the skin secretions of the South American bullfrog Leptodactylus pentadactylus. Comp Biochem Physiol C Toxicol Pharmacol. 2005 Aug;141(4):393-7.
219 A defensin-like antimicrobial peptide from the venoms of spider, Ornithoctonus hainana. J Pept Sci. 2011 Jul;17(7):540-4.
220 Antimicrobial peptides from scorpion venom induce Ca(2+) signaling in HL-60 cells. Biochem Biophys Res Commun. 2003 Nov 7;311(1):90-7.
221 Cathelicidin peptides inhibit multiply antibiotic-resistant pathogens from patients with cystic fibrosis. Antimicrob Agents Chemother. 2001 Oct;45(10):2838-44.
222 Characterization of unique amphipathic antimicrobial peptides from venom of the scorpion Pandinus imperator. Biochem J. 2001 Oct 1;359(Pt 1):35-45.
223 Induction of morphological changes in model lipid membranes and the mechanism of membrane disruption by a large scorpion-derived pore-forming peptide. Biophys J. 2005 Dec;89(6):4067-80.
224 Pore formation of phospholipid membranes by the action of two hemolytic arachnid peptides of different size. Biochim Biophys Acta. 2004 Aug 30;1664(2):182-8.
225 A novel horse alpha-defensin: gene transcription, recombinant expression and characterization of the structure and function. Biochem J. 2007 Oct 15;407(2):267-76.
226 Parabutoporin--an antibiotic peptide from scorpion venom--can both induce activation and inhibition of granulocyte cell functions. Peptides. 2004 Jul;25(7):1079-84.
227 Design and mechanism of action of a novel bacteria-selective antimicrobial peptide from the cell-penetrating peptide Pep-1. Biochem Biophys Res Commun. 2006 Oct 20;349(2):769-74.
228 Structural aspects and biological properties of the cathelicidin PMAP-36. FEBS J. 2005 Sep;272(17):4398-406.
229 Perinerin, a novel antimicrobial peptide purified from the clamworm Perinereis aibuhitensis grube and its partial characterization. J Biochem. 2004 Mar;135(3):297-304.
230 Phylloseptins: a novel class of anti-bacterial and anti-protozoan peptides from the Phyllomedusa genus. Peptides. 2005 Apr;26(4):565-73.
231 Solution NMR structures of the antimicrobial peptides phylloseptin-1, -2, and -3 and biological activity: the role of charges and hydrogen bonding interactions in stabilizing helix conformations. Peptides. 2008 Oct;29(10):1633-44.
232 Elements of the granular gland peptidome and transcriptome persist in air-dried skin of the South American orange-legged leaf frog, Phyllomedusa hypocondrialis. Peptides. 2006 Sep;27(9):2129-36.
233 Molecular cloning and biological characterization of novel antimicrobial peptides, pilosulin 3 and pilosulin 4, from a species of the Australian ant genus Myrmecia. Arch Biochem Biophys. 2004 Aug 15;428(2):170-8.
234 Identification and optimization of an antimicrobial peptide from the ant venom toxin pilosulin. Arch Biochem Biophys. 2005 Feb 15;434(2):358-64.
235 Discovery and characterization of two isoforms of moronecidin, a novel antimicrobial peptide from hybrid striped bass. J Biol Chem. 2002 Feb 15;277(7):5030-9.
236 Efficient screening of a novel antimicrobial peptide from Jatropha curcas by cell membrane affinity chromatography. J Agric Food Chem. 2011 Feb 23;59(4):1145-51.
237 Two antimicrobial and nematicidal peptides derived from sequences encoded Picea sitchensis. J Pept Sci. 2011 Sep;17(9):627-31.
238 Isolation and characterization of pleurocidin, an antimicrobial peptide in the skin secretions of winter flounder. J Biol Chem. 1997 May 2;272(18):12008-13.
239 Cloning and developmental expression of a family of pleurocidin-like antimicrobial peptides from winter flounder, Pleuronectes americanus (Walbaum). Dev Comp Immunol. 2001 Mar;25(2):137-47.
240 Identification, structure and differential expression of novel pleurocidins clustered on the genome of the winter flounder, Pseudopleuronectes americanus (Walbaum). Eur J Biochem. 2003 Sep;270(18):3720-30.
241 Structure-activity relationships for the beta-hairpin cationic antimicrobial peptide polyphemusin I. Biochim Biophys Acta. 2004 May 6;1698(2):239-50.
242 Antimicrobial peptides, isolated from horseshoe crab hemocytes, tachyplesin II, and polyphemusins I and II: chemical structures and biological activity. J Biochem. 1989 Oct;106(4):663-8.
243 Ponericins, new antibacterial and insecticidal peptides from the venom of the ant Pachycondyla goeldii. J Biol Chem. 2001 May 25;276(21):17823-9.
244 Attenuation of Pseudomonas aeruginosa virulence by marine invertebrate-derived Streptomyces sp. Lett Appl Microbiol. 2013 Mar;56(3):197-207.
245 Biosynthesis and degradation of peptides derived from Xenopus laevis prohormones. Biochem J. 1987 Apr 1;243(1):113-20.
246 Ranalexin. A novel antimicrobial peptide from bullfrog (Rana catesbeiana) skin, structurally related to the bacterial antibiotic, polymyxin. J Biol Chem. 1994 Apr 8;269(14):10849-55.
247 Solution structure of the antimicrobial peptide ranalexin and a study of its interaction with perdeuterated dodecylphosphocholine micelles. Eur J Biochem. 1998 Apr 1;253(1):221-8.
248 Post-secretory events alter the peptide content of the skin secretion of Hypsiboas raniceps. Biochem Biophys Res Commun. 2008 Dec 26;377(4):1057-61.
249 Isolation and characterization of novel antimicrobial peptides, rugosins A, B and C, from the skin of the frog, Rana rugosa. Biochem Biophys Res Commun. 1995 Jul 6;212(1):249-54.
250 Isolation, gene expression and solution structure of a novel moricin analogue, antibacterial peptide from a lepidopteran insect, Spodoptera litura. Biochim Biophys Acta. 2005 Aug 31;1752(1):83-92.
251 Structure-activity analysis of SMAP-29, a sheep leukocytes-derived antimicrobial peptide. Biochem Biophys Res Commun. 2001 Jul 27;285(4):1046-51.
252 Spheniscins, avian beta-defensins in preserved stomach contents of the king penguin, Aptenodytes patagonicus. J Biol Chem. 2003 Dec 19;278(51):51053-8.
253 Solution structure of spheniscin, a beta-defensin from the penguin stomach. J Biol Chem. 2004 Jul 16;279(29):30433-9.
254 Insect immunity. Constitutive expression of a cysteine-rich antifungal and a linear antibacterial peptide in a termite insect. J Biol Chem. 2001 Feb 9;276(6):4085-92.
255 Solution structures of stomoxyn and spinigerin, two insect antimicrobial peptides with an alpha-helical conformation. Biopolymers. 2006 Feb 5;81(2):92-103.
256 Epithelial innate immunityA novel antimicrobial peptide with antiparasitic activity in the blood-sucking insect Stomoxys calcitrans. J Biol Chem. 2002 Dec 20;277(51):49921-6.
257 Styelins, broad-spectrum antimicrobial peptides from the solitary tunicate, Styela clava. Comp Biochem Physiol B Biochem Mol Biol. 1997 Nov;118(3):515-21.
258 Direct antimicrobial properties of substance P. Life Sci. 2002 Jul 5;71(7):747-50.
259 The antimicrobial peptide tachyplesin III coated alone and in combination with intraperitoneal piperacillin-tazobactam prevents ureteral stent Pseudomonas infection in a rat subcutaneous pouch model. Peptides. 2007 Dec;28(12):2293-8.
260 Isolation, characterization and molecular cloning of new temporins from the skin of the North African ranid Pelophylax saharica. Peptides. 2008 Sep;29(9):1526-33.
261 Purification and characterization of antimicrobial peptides from the skin secretions of the carpenter frog Rana virgatipes (Ranidae, Aquarana). Regul Pept. 2005 Nov;131(1-3):38-45.
262 Temporins, antimicrobial peptides from the European red frog Rana temporaria. Eur J Biochem. 1996 Dec 15;242(3):788-92.
263 Structure-activity analysis of thanatin, a 21-residue inducible insect defense peptide with sequence homology to frog skin antimicrobial peptides. Proc Natl Acad Sci U S A. 1996 Feb 6;93(3):1221-5.
264 Purification and partial amino acid sequence of thuricin S, a new anti-Listeria bacteriocin from Bacillus thuringiensis. Can J Microbiol. 2007 Feb;53(2):284-90.
265 Antibacterial and haemolytic peptides containing D-alloisoleucine from the skin of Bombina variegata. EMBO J. 1993 Dec;12(12):4829-32.
266 A family of bombinin-related peptides from the skin of Bombina variegata. Eur J Biochem. 1991 Jul 1;199(1):217-22.
267 Tracheal antimicrobial peptide, a cysteine-rich peptide from mammalian tracheal mucosa: peptide isolation and cloning of a cDNA. Proc Natl Acad Sci U S A. 1991 May 1;88(9):3952-6.
268 Airway epithelial cells are the site of expression of a mammalian antimicrobial peptide gene. Proc Natl Acad Sci U S A. 1993 May 15;90(10):4596-600.
269 Antimicrobial activity of a 13 amino acid tryptophan-rich peptide derived from a putative porcine precursor protein of a novel family of antibacterial peptides. FEBS Lett. 1996 Jul 15;390(1):95-8.
270 Structure of the antimicrobial peptide tritrpticin bound to micelles: a distinct membrane-bound peptide fold. Biochemistry. 1999 Dec 21;38(51):16749-55.
271 Conformation-dependent antibiotic activity of tritrpticin, a cathelicidin-derived antimicrobial peptide. Biochem Biophys Res Commun. 2002 Sep 6;296(5):1044-50.
272 Role of peptide hydrophobicity in the mechanism of action of alpha-helical antimicrobial peptides. Antimicrob Agents Chemother. 2007 Apr;51(4):1398-406.
273 Role of helicity on the anticancer mechanism of action of cationic-helical peptides. Int J Mol Sci. 2012;13(6):6849-62.
274 Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index. J Biol Chem. 2005 Apr 1;280(13):12316-29.
275 Indole derivatives inhibited the formation of bacterial biofilm and modulated Ca2+ efflux in diatom. Mar Pollut Bull. 2014 Nov 15;88(1-2):62-9.
276 Synthesis and anti-biofilm activities of dihydro-pyrrol-2-one derivatives on Pseudomonas aeruginosa. Bioorg Med Chem Lett. 2015 Feb 1;25(3):597-601.
277 Pseudomonas aeruginosa-plant root interactions. Pathogenicity, biofilm formation, and root exudation. Plant Physiol. 2004 Jan;134(1):320-31.
278 Cis-2-dodecenoic acid signal modulates virulence of Pseudomonas aeruginosa through interference with quorum sensing systems and T3SS. BMC Microbiol. 2013 Oct 18;13:231.
279 Inhibition of biofilm formation, quorum sensing and infection in Pseudomonas aeruginosa by natural products-inspired organosulfur compounds. PLoS One. 2012;7(6):e38492.
280 Virtual screening for novel quorum sensing inhibitors to eradicate biofilm formation of Pseudomonas aeruginosa. Appl Microbiol Biotechnol. 2008 May;79(1):119-26.
281 ZnO nanoparticles inhibit Pseudomonas aeruginosa biofilm formation and virulence factor production. Microbiol Res. 2014 Dec;169(12):888-96.
282 Simultaneous inhibition of rhamnolipid and polyhydroxyalkanoic acid synthesis and biofilm formation in Pseudomonas aeruginosa by 2-bromoalkanoic acids: effect of inhibitor alkyl-chain-length. PLoS One. 2013 Sep 4;8(9):e73986.
283 7-fluoroindole as an antivirulence compound against Pseudomonas aeruginosa. FEMS Microbiol Lett. 2012 Apr;329(1):36-44.
284 Metabolomics-based screening of biofilm-inhibitory compounds against Pseudomonas aeruginosa from burdock leaf. Molecules. 2015 Sep 8;20(9):16266-77.
285 Deciphering the role of coumarin as a novel quorum sensing inhibitor suppressing virulence phenotypes in bacterial pathogens. Appl Microbiol Biotechnol. 2015 Apr;99(7):3303-16.
286 Marine bacterial isolates inhibit biofilm formation and disrupt mature biofilms of Pseudomonas aeruginosa PAO1. Appl Microbiol Biotechnol. 2010 Sep;88(1):341-58.
287 Antipathogenic potential of marine Bacillus spSS4 on N-acyl-homoserine-lactone-mediated virulence factors production in Pseudomonas aeruginosa (PAO1). J Biosci. 2011 Mar;36(1):55-67.
288 Anti-pathogenic Potential of Coral Associated Bacteria Isolated from Gulf of Mannar Against Pseudomonas aeruginosa. Indian J Microbiol. 2013 Mar;53(1):111-3.
289 A diketopiperazine factor from Rheinheimera aquimaris QSI02 exhibits anti-quorum sensing activity. Sci Rep. 2016 Dec 21;6:39637.
290 Quorum quenching activity in cell-free lysate of endophytic bacteria isolated from Pterocarpus santalinus Linn., and its effect on quorum sensing regulated biofilm in Pseudomonas aeruginosa PAO1. Microbiol Res. 2014 Jul-Aug;169(7-8):561-9.
291 Inhibition of quorum sensing-controlled virulence factors and biofilm formation in Pseudomonas aeruginosa by culture extract from novel bacterial species of Paenibacillus using a rat model of chronic lung infection. Int J Bacteriol. 2015;2015:671562.
292 A medicinal herb Cassia alata attenuates quorum sensing in Chromobacterium violaceum and Pseudomonas aeruginosa. Lett Appl Microbiol. 2017 Mar;64(3):231-238.
293 Diarylheptanoids from Alnus viridis sspviridis and Alnus glutinosa: modulation of quorum sensing activity in Pseudomonas aeruginosa. Planta Med. 2017 Jan;83(1-02):117-125.
294 Ajoene, a sulfur-rich molecule from garlic, inhibits genes controlled by quorum sensing. Antimicrob Agents Chemother. 2012 May;56(5):2314-25.
295 Anti-biofilm effects of anthranilate on a broad range of bacteria. Sci Rep. 2017 Aug 17;7(1):8604.
296 Disruption in quorum-sensing systems and bacterial biofilm inhibition by cembranoid diterpenes isolated from the octocoral Eunicea knighti. J Nat Prod. 2012 Sep 28;75(9):1637-42.
297 Quorum sensing signalling and biofilm formation of brewery-derived bacteria, and inhibition of signalling by natural compounds. Curr Microbiol. 2014 Nov;69(5):617-27.
298 Screening for novel quorum-sensing inhibitors to interfere with the formation of Pseudomonas aeruginosa biofilm. J Med Microbiol. 2011 Dec;60(Pt 12):1827-1834.
299 Effect of cinnamon oil on quorum sensing-controlled virulence factors and biofilm formation in Pseudomonas aeruginosa. PLoS One. 2015 Aug 11;10(8):e0135495.
300 Correlation of quorum sensing and virulence factors in Pseudomonas aeruginosa isolates in Egypt. J Infect Dev Ctries. 2015 Oct 29;9(10):1091-9.
301 Hyperoside inhibits biofilm formation of Pseudomonas aeruginosa. Exp Ther Med. 2017 Aug;14(2):1647-1652.
302 Malabaricone C from Myristica cinnamomea exhibits anti-quorum sensing activity. J Nat Prod. 2011 Oct 28;74(10):2261-4.
303 An insight into anti-biofilm and anti-quorum sensing activities of the selected anthocyanidins: the case study of Pseudomonas aeruginosa PAO1. Nat Prod Res. 2017 May;31(10):1177-1180.
304 Penicillenols from a deep-sea fungus Aspergillus restrictus inhibit Candida albicans biofilm formation and hyphal growth. J Antibiot (Tokyo). 2017 Jun;70(6):763-770.
305 Isolate-specific effects of patulin, penicillic Acid and EDTA on biofilm formation and growth of dental unit water line biofilm isolates. Curr Microbiol. 2010 Aug;61(2):148-56.
306 Sub-MICs of Mentha piperita essential oil and menthol inhibits AHL mediated quorum sensing and biofilm of Gram-negative bacteria. Front Microbiol. 2015 May 13;6:420.
307 Inhibition of Pseudomonas aeruginosa and Escherichia coli O157:H7 biofilm formation by plant metabolite -viniferin. J Agric Food Chem. 2013 Jul 24;61(29):7120-6.
308 Scaffold of selenium nanovectors and honey phytochemicals for inhibition of Pseudomonas aeruginosa quorum sensing and biofilm formation. Front Cell Infect Microbiol. 2017 Mar 23;7:93.
309 Zingerone inhibit biofilm formation and improve antibiofilm efficacy of ciprofloxacin against Pseudomonas aeruginosa PAO1. Fitoterapia. 2013 Oct;90:73-8.
310 Attenuation of Pseudomonas aeruginosa biofilm formation by Vitexin: a combinatorial study with azithromycin and gentamicin. Sci Rep. 2016 Mar 22;6:23347.
311 Egg wax from the cattle tick Rhipicephalus (Boophilus) microplus inhibits Pseudomonas aeruginosa biofilm. Ticks Tick Borne Dis. 2013 Sep;4(5):366-76.
312 Agaricus blazei hot water extract shows anti quorum sensing activity in the nosocomial human pathogen Pseudomonas aeruginosa. Molecules. 2014 Apr 3;19(4):4189-99.
313 Inhibition of bacterial quorum sensing and biofilm formation by extracts of neotropical rainforest plants. Planta Med. 2014 Mar;80(4):343-50.
314 The effect of burdock leaf fraction on adhesion, biofilm formation, quorum sensing and virulence factors of Pseudomonas aeruginosa. J Appl Microbiol. 2017 Mar;122(3):615-624.
315 Antiquorum sensing and antibiofilm potential of Capparis spinosa. Arch Med Res. 2011 Nov;42(8):658-68.
316 Endemic malagasy Dalbergia species inhibit quorum sensing in Pseudomonas aeruginosa PAO1. Microbiology. 2013 May;159(Pt 5):924-938.
317 Inhibition of quorum sensing in Pseudomonas aeruginosa by two herbal essential oils from Apiaceae family. J Microbiol. 2015 Feb;53(2):176-80.
318 Antimicrobial, antitrypanosomal and antibiofilm activity of Equisetum hyemale. Microb Pathog. 2016 Dec;101:119-125.
319 Screening for quorum-sensing inhibitors (QSI) by use of a novel genetic system, the QSI selector. J Bacteriol. 2005 Mar;187(5):1799-814.
320 Ginger extract inhibits biofilm formation by Pseudomonas aeruginosa PA14. PLoS One. 2013 Sep 27;8(9):e76106.
321 Inhibition of Pseudomonas aeruginosa biofilm formation by traditional Chinese medicinal herb Herba patriniae. Biomed Res Int. 2017;2017:9584703.
322 Antimicrobial properties of Kalanchoe blossfeldiana: a focus on drug resistance with particular reference to quorum sensing-mediated bacterial biofilm formation. J Pharm Pharmacol. 2015 Jul;67(7):951-62.
323 Lagerstroemia speciosa fruit extract modulates quorum sensing-controlled virulence factor production and biofilm formation in Pseudomonas aeruginosa. Microbiology. 2012 Feb;158(Pt 2):529-538.
324 Leaf extracts of Mangifera indica L. inhibit quorum sensing - regulated production of virulence factors and biofilm in test bacteria. Front Microbiol. 2017 Apr 24;8:727.
325 Influence of clove oil on certain quorum-sensing-regulated functions and biofilm of Pseudomonas aeruginosa and Aeromonas hydrophila. J Biosci. 2013 Dec;38(5):835-44.
326 Ellagic acid derivatives from Terminalia chebula Retzdownregulate the expression of quorum sensing genes to attenuate Pseudomonas aeruginosa PAO1 virulence. PLoS One. 2013;8(1):e53441.
327 The inhibitory effect of Thymus vulgaris extracts on the planktonic form and biofilm structures of six human pathogenic bacteria. Avicenna J Phytomed. 2015 Jul-Aug;5(4):309-18.
328 In search of alternative antibiotic drugs: quorum-quenching activity in sponges and their bacterial isolates. Front Microbiol. 2016 Apr 5;7:416.
329 The influence of azithromycin on the biofilm formation of Pseudomonas aeruginosa in vitro. Chemotherapy. 1996 May-Jun;42(3):186-91.
330 Trigonella foenum-graceum (Seed) extract interferes with quorum sensing regulated traits and biofilm formation in the strains of pseudomonas aeruginosa and aeromonas hydrophila. Evid Based Complement Alternat Med. 2015;2015:879540.
331 Synergistic activity of sub-inhibitory concentrations of curcumin with ceftazidime and ciprofloxacin against Pseudomonas aeruginosa quorum sensing related genes and virulence traits. World J Microbiol Biotechnol. 2017 Mar;33(3):50.
332 Inhibition of multidrug efflux as a strategy to prevent biofilm formation. J Antimicrob Chemother. 2014 Mar;69(3):673-81.
333 Effects of ciprofloxacin and protamine sulfate combinations against catheter-associated Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother. 1995 Jun;39(6):1281-6.
334 Inhibition of bacterial biofilms by carboxymethyl chitosan combined with silver, zinc and copper salts. Int J Biol Macromol. 2017 Dec;105(Pt 1):385-392.
335 Inhibition of virulence factors of Pseudomonas aeruginosa by diclofenac sodium. Roum Arch Microbiol Immunol. 2015 Jul-Dec;74(3-4):79-85.
336 Potential use of dimethyl sulfoxide in treatment of infections caused by Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2016 Nov 21;60(12):7159-7169.
337 Doxycycline interferes with quorum sensing-mediated virulence factors and biofilm formation in gram-negative bacteria. World J Microbiol Biotechnol. 2013 Jun;29(6):949-57.
338 Effect of quorum quenching lactonase in clinical isolates of Pseudomonas aeruginosa and comparison with quorum sensing inhibitors. Front Microbiol. 2017 Feb 14;8:227.
339 Lysozyme associated liposomal gentamicin inhibits bacterial biofilm. Int J Mol Sci. 2017 Apr 9;18(4).
340 Formation of the Pseudomonas aeruginosa PAO1 biofilms in the presence of hydrogen peroxide; the effect of the AiiA gene. Mol Gen Mikrobiol Virusol. 2013;(4):10-4.
341 The inhibitory effect of micafungin on biofilm formation by Pseudomonas aeruginosa. Biofouling. 2013 Sep;29(8):909-15.
342 New life for an old drug: the anthelmintic drug niclosamide inhibits Pseudomonas aeruginosa quorum sensing. Antimicrob Agents Chemother. 2013 Feb;57(2):996-1005.
343 The quorum sensing inhibitor hamamelitannin increases antibiotic susceptibility of Staphylococcus aureus biofilms by affecting peptidoglycan biosynthesis and eDNA release. Sci Rep. 2016 Feb 1;6:20321.
344 Oral administration of the broad-spectrum antibiofilm compound toremifene inhibits Candida albicans and Staphylococcus aureus biofilm formation in vivo. Antimicrob Agents Chemother. 2014 Dec;58(12):7606-10.
345 Identification of catechin as one of the flavonoids from Combretum albiflorum bark extract that reduces the production of quorum-sensing-controlled virulence factors in Pseudomonas aeruginosa PAO1. Appl Environ Microbiol. 2010 Jan;76(1):243-53.
346 Sodium ascorbate as a quorum sensing inhibitor of Pseudomonas aeruginosa. J Appl Microbiol. 2014 Nov;117(5):1388-99.
347 Inhibition of biofilm development of uropathogens by curcumin - an anti-quorum sensing agent from Curcuma longa. Food Chem. 2014 Apr 1;148:453-60.
348 Biodegradation of poly(anhydride-esters) into non-steroidal anti-inflammatory drugs and their effect on Pseudomonas aeruginosa biofilms in vitro and on the foreign-body response in vivo. Biomaterials. 2006 Oct;27(29):5039-48.
349 Differential gene expression for investigation of Escherichia coli biofilm inhibition by plant extract ursolic acid. Appl Environ Microbiol. 2005 Jul;71(7):4022-34.
350 Effects of allicin on the formation of Pseudomonas aeruginosa biofinm and the production of quorum-sensing controlled virulence factors. Pol J Microbiol. 2013;62(3):243-51.
351 The natural antimicrobial carvacrol inhibits quorum sensing in Chromobacterium violaceum and reduces bacterial biofilm formation at sub-lethal concentrations. PLoS One. 2014 Apr 1;9(4):e93414.
352 Palmitoyl-DL-carnitine is a multitarget inhibitor of Pseudomonas aeruginosa biofilm development. Chembiochem. 2011 Dec 16;12(18):2759-66.
353 Quercetin is an effective inhibitor of quorum sensing, biofilm formation and virulence factors in Pseudomonas aeruginosa. J Appl Microbiol. 2016 Apr;120(4):966-74.
354 Cis-9-octadecenoic acid from the rhizospheric bacterium Stenotrophomonas maltophilia BJ01 shows quorum quenching and anti-biofilm activities. Biofouling. 2013;29(7):855-67.
355 Eugenol inhibits quorum sensing at sub-inhibitory concentrations. Biotechnol Lett. 2013 Apr;35(4):631-7.
356 6-Gingerol reduces Pseudomonas aeruginosa biofilm formation and virulence via quorum sensing inhibition. Sci Rep. 2015 Mar 2;5:8656.
357 Synthesis and evaluation of antibacterial activities of andrographolide analogues. Eur J Med Chem. 2009 Jul;44(7):2936-43.
358 Inhibition of swarming motility of Pseudomonas aeruginosa by branched-chain fatty acids. FEMS Microbiol Lett. 2008 Apr;281(1):81-6.
359 Furvina inhibits the 3-oxo-C12-HSL-based quorum sensing system of Pseudomonas aeruginosa and QS-dependent phenotypes. Biofouling. 2017 Feb;33(2):156-168.
360 Synthetic organic compounds with potential for bacterial biofilm inhibition, a path for the identification of compounds interfering with quorum sensing. Int J Antimicrob Agents. 2013 Dec;42(6):519-23.
361 Activity of norspermidine on bacterial biofilms of multidrug-resistant clinical isolates associated with persistent extremity wound infections. Adv Exp Med Biol. 2017;973:53-70.
362 Inhibitory effects of 2,2'-dipyridyl and 1,2,3,4,6-penta-O-galloyl-b-D-glucopyranose on biofilm formation in contact lens cases. Invest Ophthalmol Vis Sci. 2015 Nov;56(12):7053-7.
363 Involvement of quorum sensing genes in biofilm development and degradation of polycyclic aromatic hydrocarbons by a marine bacterium Pseudomonas aeruginosa N6P6. Appl Microbiol Biotechnol. 2015 Dec;99(23):10283-97.
364 Inhibitory effects of 4-hydroxy-2,5-dimethyl-3(2H)-furanone (HDMF) on acyl-homoserine lactone-mediated virulence factor production and biofilm formation in Pseudomonas aeruginosa PAO1. J Microbiol. 2014 Sep;52(9):734-42.
365 Reducing virulence and biofilm of Pseudomonas aeruginosa by potential quorum sensing inhibitor carotenoid: zeaxanthin. Microb Ecol. 2017 Aug;74(2):466-473.
366 Potentiation of tobramycin by silver nanoparticles against Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother. 2017 Oct 24;61(11).
367 Reverting antibiotic tolerance of Pseudomonas aeruginosa PAO1 persister cells by (Z)-4-bromo-5-(bromomethylene)-3-methylfuran-2(5H)-one. PLoS One. 2012;7(9):e45778.
368 Development of inhibitors against TraR quorum-sensing system in Agrobacterium tumefaciens by molecular modeling of the ligand-receptor interaction. Mol Cells. 2009 Nov 30;28(5):447-53.
369 Aryl rhodanines specifically inhibit staphylococcal and enterococcal biofilm formation. Antimicrob Agents Chemother. 2009 Oct;53(10):4357-67.
370 Long-chain 4-aminoquinolines as quorum sensing inhibitors in Serratia marcescens and Pseudomonas aeruginosa. ACS Chem Biol. 2017 May 19;12(5):1425-1434.
371 Synthesis and biological evaluation of novel acyclic and cyclic glyoxamide based derivatives as bacterial quorum sensing and biofilm inhibitors. Org Biomol Chem. 2017 Jul 21;15(27):5743-5755.
372 Effect of furanone on experimentally induced Pseudomonas aeruginosa biofilm formation: in vitro study. Int J Pediatr Otorhinolaryngol. 2012 Nov;76(11):1575-8.
373 Bioactive sesqui- and diterpenoids from the Argentine liverwort Porella chilensis. J Nat Prod. 2011 Apr 25;74(4):574-9.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.